Source Name	Provider	Material Type	Term Source REF	Characteristics[Organism]	Term Source REF	Characteristics[Sex]	Term Source REF	Characteristics[DiseaseState]	Term Source REF	Comment[OCG Cohort]	Sample Name	Material Type	Term Source REF	Characteristics[OrganismPart]	Term Source REF	Description	Protocol REF	Performer	Extract Name	Material Type	Term Source REF	Comment[SRA_SAMPLE]	Protocol REF	Protocol REF	Performer	Extract Name	Comment[LIBRARY_LAYOUT]	Comment[LIBRARY_SOURCE]	Comment[LIBRARY_STRATEGY]	Comment[LIBRARY_SELECTION]	Comment[LIBRARY_NAME]	Comment[SRA_EXPERIMENT]	Description	Protocol REF	Performer	Assay Name	Technology Type	Term Source REF	Comment[SPOT_LENGTH]	Protocol REF	Protocol REF	Derived Array Data File	Comment[SRA_RUN]	Comment[SRA_FILE_URI]	Comment[OCG Data Level]	Comment[ASSEMBLY_NAME]
TARGET-15-PARWPU	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-PARWPU-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-PARWPU-09A.1-01D	DNA	EFO	SRS2495556	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-PARWPU-09A.1-01D SJMPAL016341_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL016341_D2	SRX3325135	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-PARWPU-09A.1-01D SJMPAL016341_D2 run	sequencing assay	EFO	185	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL016341_D2.bam	SRR6216500	@dbgap@:reads/SRP011999/SRS2495556/SRX3325135/SRR6216500/SRR6216500.sra	2	GRCh37
TARGET-15-PARWPU	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-PARWPU-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-PARWPU-09A.2-01D	DNA	EFO	SRS2629629	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-PARWPU-09A.2-01D SJMPAL016341_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL016341_D3	SRX3325136	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-PARWPU-09A.2-01D SJMPAL016341_D3 run	sequencing assay	EFO	187	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL016341_D3.bam	SRR6216501	@dbgap@:reads/SRP011999/SRS2629629/SRX3325136/SRR6216501/SRR6216501.sra	2	GRCh37
TARGET-15-PARWPU	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-PARWPU-09A.3	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-PARWPU-09A.3-01D	DNA	EFO	SRS2629630	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-PARWPU-09A.3-01D SJMPAL016341_D4 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL016341_D4	SRX3325137	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-PARWPU-09A.3-01D SJMPAL016341_D4 run	sequencing assay	EFO	185	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL016341_D4.bam	SRR6216502	@dbgap@:reads/SRP011999/SRS2629630/SRX3325137/SRR6216502/SRR6216502.sra	2	GRCh37
TARGET-15-PARWPU	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-PARWPU-14A.1	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-PARWPU-14A.1-01D	DNA	EFO	SRS1761126	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-PARWPU-14A.1-01D SJMPAL016341_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL016341_G1	SRX3325138	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-PARWPU-14A.1-01D SJMPAL016341_G1 run	sequencing assay	EFO	189	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL016341_G1.bam	SRR6216503	@dbgap@:reads/SRP011999/SRS1761126/SRX3325138/SRR6216503/SRR6216503.sra	2	GRCh37
TARGET-15-SJMLL003311	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMLL003311-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMLL003311-09A.1-01D	DNA	EFO	SRS2623591	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMLL003311-09A.1-01D SJMLL003311_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMLL003311_D3	SRX3318016	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMLL003311-09A.1-01D SJMLL003311_D3 run	sequencing assay	EFO	194	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMLL003311_D3.bam	SRR6208738	@dbgap@:reads/SRP011999/SRS2623591/SRX3318016/SRR6208738/SRR6208738.sra	2	GRCh37
TARGET-15-SJMLL003311	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMLL003311-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMLL003311-09A.2-01D	DNA	EFO	SRS2623593	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMLL003311-09A.2-01D SJMLL003311_D4 library	PAIRED	GENOMIC	WXS	RANDOM	SJMLL003311_D4	SRX3318017	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMLL003311-09A.2-01D SJMLL003311_D4 run	sequencing assay	EFO	191	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMLL003311_D4.bam	SRR6208739	@dbgap@:reads/SRP011999/SRS2623593/SRX3318017/SRR6208739/SRR6208739.sra	2	GRCh37
TARGET-15-SJMLL003311	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMLL003311-14A	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMLL003311-14A-01D	DNA	EFO	SRS2623594	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMLL003311-14A-01D SJMLL003311_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMLL003311_G1	SRX3318018	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMLL003311-14A-01D SJMLL003311_G1 run	sequencing assay	EFO	202	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMLL003311_G1.bam	SRR6208740	@dbgap@:reads/SRP011999/SRS2623594/SRX3318018/SRR6208740/SRR6208740.sra	2	GRCh37
TARGET-15-SJMPAL003414	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Recurrent Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL003414-04A.1	organism part	EFO	Bone Marrow	NCIt	"Recurrent Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL003414-04A.1-01D	DNA	EFO	SRS2495540	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL003414-04A.1-01D SJMPAL003414_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL003414_D2	SRX3325094	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL003414-04A.1-01D SJMPAL003414_D2 run	sequencing assay	EFO	171	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL003414_D2.bam	SRR6216459	@dbgap@:reads/SRP011999/SRS2495540/SRX3325094/SRR6216459/SRR6216459.sra	2	GRCh37
TARGET-15-SJMPAL004013	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Recurrent Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL004013-04A.1	organism part	EFO	Bone Marrow	NCIt	"Recurrent Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL004013-04A.1-01D	DNA	EFO	SRS2629601	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL004013-04A.1-01D SJMPAL004013_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL004013_D2	SRX3325095	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL004013-04A.1-01D SJMPAL004013_D2 run	sequencing assay	EFO	183	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL004013_D2.bam	SRR6216460	@dbgap@:reads/SRP011999/SRS2629601/SRX3325095/SRR6216460/SRR6216460.sra	2	GRCh37
TARGET-15-SJMPAL004013	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL004013-15A	organism part	EFO	Bone Marrow	NCIt	"Fibroblasts from Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL004013-15A-01D	DNA	EFO	SRS2629602	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL004013-15A-01D SJMPAL004013_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL004013_G1	SRX3325096	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL004013-15A-01D SJMPAL004013_G1 run	sequencing assay	EFO	189	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL004013_G1.bam	SRR6216461	@dbgap@:reads/SRP011999/SRS2629602/SRX3325096/SRR6216461/SRR6216461.sra	2	GRCh37
TARGET-15-SJMPAL005001	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Recurrent Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL005001-04A	organism part	EFO	Bone Marrow	NCIt	"Recurrent Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL005001-04A-01D	DNA	EFO	SRS2495541	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL005001-04A-01D SJMPAL005001_R4 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL005001_R4	SRX3325097	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL005001-04A-01D SJMPAL005001_R4 run	sequencing assay	EFO	202	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL005001_R4.bam	SRR6216462	@dbgap@:reads/SRP011999/SRS2495541/SRX3325097/SRR6216462/SRR6216462.sra	2	GRCh37
TARGET-15-SJMPAL011911	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL011911-03A.1	organism part	EFO	Peripheral Blood	NCIt	"Primary Blood Derived Cancer - Peripheral Blood"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL011911-03A.1-01D	DNA	EFO	SRS2495544	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL011911-03A.1-01D SJMPAL011911_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL011911_D2	SRX3325098	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL011911-03A.1-01D SJMPAL011911_D2 run	sequencing assay	EFO	202	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL011911_D2.bam	SRR6216463	@dbgap@:reads/SRP011999/SRS2495544/SRX3325098/SRR6216463/SRR6216463.sra	2	GRCh37
TARGET-15-SJMPAL011911	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL011911-03A	organism part	EFO	Peripheral Blood	NCIt	"Primary Blood Derived Cancer - Peripheral Blood"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL011911-03A-01D	DNA	EFO	SRS2495543	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL011911-03A-01D SJMPAL011911_D1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL011911_D1	SRX3325099	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL011911-03A-01D SJMPAL011911_D1 run	sequencing assay	EFO	202	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL011911_D1.bam	SRR6216464	@dbgap@:reads/SRP011999/SRS2495543/SRX3325099/SRR6216464/SRR6216464.sra	2	GRCh37
TARGET-15-SJMPAL011911	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL011911-10A	organism part	EFO	Peripheral Blood	NCIt	"Blood Derived Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL011911-10A-01D	DNA	EFO	SRS2629603	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL011911-10A-01D SJMPAL011911_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL011911_G1	SRX3325100	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL011911-10A-01D SJMPAL011911_G1 run	sequencing assay	EFO	202	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL011911_G1.bam	SRR6216465	@dbgap@:reads/SRP011999/SRS2629603/SRX3325100/SRR6216465/SRR6216465.sra	2	GRCh37
TARGET-15-SJMPAL011912	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL011912-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL011912-09A.1-01D	DNA	EFO	SRS2629604	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL011912-09A.1-01D SJMPAL011912_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL011912_D2	SRX3325101	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL011912-09A.1-01D SJMPAL011912_D2 run	sequencing assay	EFO	202	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL011912_D2.bam	SRR6216466	@dbgap@:reads/SRP011999/SRS2629604/SRX3325101/SRR6216466/SRR6216466.sra	2	GRCh37
TARGET-15-SJMPAL011912	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL011912-14A	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL011912-14A-01D	DNA	EFO	SRS2629605	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL011912-14A-01D SJMPAL011912_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL011912_G1	SRX3325102	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL011912-14A-01D SJMPAL011912_G1 run	sequencing assay	EFO	202	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL011912_G1.bam	SRR6216467	@dbgap@:reads/SRP011999/SRS2629605/SRX3325102/SRR6216467/SRR6216467.sra	2	GRCh37
TARGET-15-SJMPAL011913	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL011913-09A	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL011913-09A-01D	DNA	EFO	SRS2495546	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL011913-09A-01D SJMPAL011913_D1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL011913_D1	SRX3325103	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL011913-09A-01D SJMPAL011913_D1 run	sequencing assay	EFO	202	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL011913_D1.bam	SRR6216468	@dbgap@:reads/SRP011999/SRS2495546/SRX3325103/SRR6216468/SRR6216468.sra	2	GRCh37
TARGET-15-SJMPAL011914	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL011914-09A	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL011914-09A-01D	DNA	EFO	SRS1761200	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL011914-09A-01D SJMPAL011914_D1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL011914_D1	SRX3325104	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL011914-09A-01D SJMPAL011914_D1 run	sequencing assay	EFO	202	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL011914_D1.bam	SRR6216469	@dbgap@:reads/SRP011999/SRS1761200/SRX3325104/SRR6216469/SRR6216469.sra	2	GRCh37
TARGET-15-SJMPAL011914	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL011914-14A	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL011914-14A-01D	DNA	EFO	SRS1761121	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL011914-14A-01D SJMPAL011914_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL011914_G1	SRX3325105	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL011914-14A-01D SJMPAL011914_G1 run	sequencing assay	EFO	202	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL011914_G1.bam	SRR6216470	@dbgap@:reads/SRP011999/SRS1761121/SRX3325105/SRR6216470/SRR6216470.sra	2	GRCh37
TARGET-15-SJMPAL011915	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL011915-09A	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL011915-09A-01D	DNA	EFO	SRS2495549	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL011915-09A-01D SJMPAL011915_D1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL011915_D1	SRX3325106	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL011915-09A-01D SJMPAL011915_D1 run	sequencing assay	EFO	202	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL011915_D1.bam	SRR6216471	@dbgap@:reads/SRP011999/SRS2495549/SRX3325106/SRR6216471/SRR6216471.sra	2	GRCh37
TARGET-15-SJMPAL011915	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL011915-14A	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL011915-14A-01D	DNA	EFO	SRS2629606	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL011915-14A-01D SJMPAL011915_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL011915_G1	SRX3325107	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL011915-14A-01D SJMPAL011915_G1 run	sequencing assay	EFO	202	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL011915_G1.bam	SRR6216472	@dbgap@:reads/SRP011999/SRS2629606/SRX3325107/SRR6216472/SRR6216472.sra	2	GRCh37
TARGET-15-SJMPAL012417	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL012417-09A	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL012417-09A-01D	DNA	EFO	SRS2495548	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL012417-09A-01D SJMPAL012417_D1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL012417_D1	SRX3325108	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL012417-09A-01D SJMPAL012417_D1 run	sequencing assay	EFO	187	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL012417_D1.bam	SRR6216473	@dbgap@:reads/SRP011999/SRS2495548/SRX3325108/SRR6216473/SRR6216473.sra	2	GRCh37
TARGET-15-SJMPAL012418	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL012418-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL012418-09A.1-01D	DNA	EFO	SRS2629607	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL012418-09A.1-01D SJMPAL012418_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL012418_D2	SRX3325109	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL012418-09A.1-01D SJMPAL012418_D2 run	sequencing assay	EFO	195	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL012418_D2.bam	SRR6216474	@dbgap@:reads/SRP011999/SRS2629607/SRX3325109/SRR6216474/SRR6216474.sra	2	GRCh37
TARGET-15-SJMPAL012418	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL012418-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL012418-09A.2-01D	DNA	EFO	SRS2629608	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL012418-09A.2-01D SJMPAL012418_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL012418_D3	SRX3325110	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL012418-09A.2-01D SJMPAL012418_D3 run	sequencing assay	EFO	195	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL012418_D3.bam	SRR6216475	@dbgap@:reads/SRP011999/SRS2629608/SRX3325110/SRR6216475/SRR6216475.sra	2	GRCh37
TARGET-15-SJMPAL012418	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL012418-09A.3	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL012418-09A.3-01D	DNA	EFO	SRS2629609	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL012418-09A.3-01D SJMPAL012418_D4 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL012418_D4	SRX3325111	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL012418-09A.3-01D SJMPAL012418_D4 run	sequencing assay	EFO	201	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL012418_D4.bam	SRR6216476	@dbgap@:reads/SRP011999/SRS2629609/SRX3325111/SRR6216476/SRR6216476.sra	2	GRCh37
TARGET-15-SJMPAL012418	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL012418-14A	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL012418-14A-01D	DNA	EFO	SRS2629610	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL012418-14A-01D SJMPAL012418_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL012418_G1	SRX3325112	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL012418-14A-01D SJMPAL012418_G1 run	sequencing assay	EFO	185	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL012418_G1.bam	SRR6216477	@dbgap@:reads/SRP011999/SRS2629610/SRX3325112/SRR6216477/SRR6216477.sra	2	GRCh37
TARGET-15-SJMPAL012419	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Recurrent Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL012419-04A.1	organism part	EFO	Bone Marrow	NCIt	"Recurrent Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL012419-04A.1-01D	DNA	EFO	SRS2629611	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL012419-04A.1-01D SJMPAL012419_R2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL012419_R2	SRX3325113	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL012419-04A.1-01D SJMPAL012419_R2 run	sequencing assay	EFO	196	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL012419_R2.bam	SRR6216478	@dbgap@:reads/SRP011999/SRS2629611/SRX3325113/SRR6216478/SRR6216478.sra	2	GRCh37
TARGET-15-SJMPAL012419	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL012419-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL012419-09A.1-01D	DNA	EFO	SRS1761196	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL012419-09A.1-01D SJMPAL012419_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL012419_D2	SRX3325114	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL012419-09A.1-01D SJMPAL012419_D2 run	sequencing assay	EFO	202	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL012419_D2.bam	SRR6216479	@dbgap@:reads/SRP011999/SRS1761196/SRX3325114/SRR6216479/SRR6216479.sra	2	GRCh37
TARGET-15-SJMPAL012419	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL012419-14A	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL012419-14A-01D	DNA	EFO	SRS1761130	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL012419-14A-01D SJMPAL012419_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL012419_G1	SRX3325115	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL012419-14A-01D SJMPAL012419_G1 run	sequencing assay	EFO	168	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL012419_G1.bam	SRR6216480	@dbgap@:reads/SRP011999/SRS1761130/SRX3325115/SRR6216480/SRR6216480.sra	2	GRCh37
TARGET-15-SJMPAL012420	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL012420-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL012420-09A.1-01D	DNA	EFO	SRS2629612	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL012420-09A.1-01D SJMPAL012420_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL012420_D2	SRX3325116	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL012420-09A.1-01D SJMPAL012420_D2 run	sequencing assay	EFO	191	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL012420_D2.bam	SRR6216481	@dbgap@:reads/SRP011999/SRS2629612/SRX3325116/SRR6216481/SRR6216481.sra	2	GRCh37
TARGET-15-SJMPAL012420	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL012420-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL012420-09A.2-01D	DNA	EFO	SRS2629613	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL012420-09A.2-01D SJMPAL012420_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL012420_D3	SRX3325117	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL012420-09A.2-01D SJMPAL012420_D3 run	sequencing assay	EFO	192	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL012420_D3.bam	SRR6216482	@dbgap@:reads/SRP011999/SRS2629613/SRX3325117/SRR6216482/SRR6216482.sra	2	GRCh37
TARGET-15-SJMPAL012420	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL012420-14A	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL012420-14A-01D	DNA	EFO	SRS2629614	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL012420-14A-01D SJMPAL012420_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL012420_G1	SRX3325118	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL012420-14A-01D SJMPAL012420_G1 run	sequencing assay	EFO	141	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL012420_G1.bam	SRR6216483	@dbgap@:reads/SRP011999/SRS2629614/SRX3325118/SRR6216483/SRR6216483.sra	2	GRCh37
TARGET-15-SJMPAL012422	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL012422-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL012422-09A.1-01D	DNA	EFO	SRS2629615	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL012422-09A.1-01D SJMPAL012422_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL012422_D2	SRX3325119	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL012422-09A.1-01D SJMPAL012422_D2 run	sequencing assay	EFO	192	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL012422_D2.bam	SRR6216484	@dbgap@:reads/SRP011999/SRS2629615/SRX3325119/SRR6216484/SRR6216484.sra	2	GRCh37
TARGET-15-SJMPAL012422	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL012422-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL012422-09A.2-01D	DNA	EFO	SRS2629616	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL012422-09A.2-01D SJMPAL012422_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL012422_D3	SRX3325120	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL012422-09A.2-01D SJMPAL012422_D3 run	sequencing assay	EFO	190	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL012422_D3.bam	SRR6216485	@dbgap@:reads/SRP011999/SRS2629616/SRX3325120/SRR6216485/SRR6216485.sra	2	GRCh37
TARGET-15-SJMPAL012422	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL012422-09A.3	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL012422-09A.3-01D	DNA	EFO	SRS2629617	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL012422-09A.3-01D SJMPAL012422_D4 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL012422_D4	SRX3325121	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL012422-09A.3-01D SJMPAL012422_D4 run	sequencing assay	EFO	183	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL012422_D4.bam	SRR6216486	@dbgap@:reads/SRP011999/SRS2629617/SRX3325121/SRR6216486/SRR6216486.sra	2	GRCh37
TARGET-15-SJMPAL012422	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL012422-14A	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL012422-14A-01D	DNA	EFO	SRS2629618	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL012422-14A-01D SJMPAL012422_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL012422_G1	SRX3325122	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL012422-14A-01D SJMPAL012422_G1 run	sequencing assay	EFO	180	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL012422_G1.bam	SRR6216487	@dbgap@:reads/SRP011999/SRS2629618/SRX3325122/SRR6216487/SRR6216487.sra	2	GRCh37
TARGET-15-SJMPAL012424	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL012424-03A.1	organism part	EFO	Peripheral Blood	NCIt	"Primary Blood Derived Cancer - Peripheral Blood"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL012424-03A.1-01D	DNA	EFO	SRS2629619	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL012424-03A.1-01D SJMPAL012424_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL012424_D2	SRX3325123	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL012424-03A.1-01D SJMPAL012424_D2 run	sequencing assay	EFO	173	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL012424_D2.bam	SRR6216488	@dbgap@:reads/SRP011999/SRS2629619/SRX3325123/SRR6216488/SRR6216488.sra	2	GRCh37
TARGET-15-SJMPAL012424	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL012424-03A.2	organism part	EFO	Peripheral Blood	NCIt	"Primary Blood Derived Cancer - Peripheral Blood"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL012424-03A.2-01D	DNA	EFO	SRS2629620	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL012424-03A.2-01D SJMPAL012424_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL012424_D3	SRX3325124	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL012424-03A.2-01D SJMPAL012424_D3 run	sequencing assay	EFO	154	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL012424_D3.bam	SRR6216489	@dbgap@:reads/SRP011999/SRS2629620/SRX3325124/SRR6216489/SRR6216489.sra	2	GRCh37
TARGET-15-SJMPAL012424	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL012424-14A	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL012424-14A-01D	DNA	EFO	SRS2629621	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL012424-14A-01D SJMPAL012424_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL012424_G1	SRX3325125	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL012424-14A-01D SJMPAL012424_G1 run	sequencing assay	EFO	141	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL012424_G1.bam	SRR6216490	@dbgap@:reads/SRP011999/SRS2629621/SRX3325125/SRR6216490/SRR6216490.sra	2	GRCh37
TARGET-15-SJMPAL012425	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL012425-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL012425-09A.1-01D	DNA	EFO	SRS2629622	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL012425-09A.1-01D SJMPAL012425_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL012425_D2	SRX3325126	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL012425-09A.1-01D SJMPAL012425_D2 run	sequencing assay	EFO	200	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL012425_D2.bam	SRR6216491	@dbgap@:reads/SRP011999/SRS2629622/SRX3325126/SRR6216491/SRR6216491.sra	2	GRCh37
TARGET-15-SJMPAL012425	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL012425-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL012425-09A.2-01D	DNA	EFO	SRS2629623	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL012425-09A.2-01D SJMPAL012425_D4 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL012425_D4	SRX3325127	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL012425-09A.2-01D SJMPAL012425_D4 run	sequencing assay	EFO	201	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL012425_D4.bam	SRR6216492	@dbgap@:reads/SRP011999/SRS2629623/SRX3325127/SRR6216492/SRR6216492.sra	2	GRCh37
TARGET-15-SJMPAL012425	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL012425-14A.1	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL012425-14A.1-01D	DNA	EFO	SRS2629624	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL012425-14A.1-01D SJMPAL012425_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL012425_G1	SRX3325128	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL012425-14A.1-01D SJMPAL012425_G1 run	sequencing assay	EFO	200	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL012425_G1.bam	SRR6216493	@dbgap@:reads/SRP011999/SRS2629624/SRX3325128/SRR6216493/SRR6216493.sra	2	GRCh37
TARGET-15-SJMPAL012426	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL012426-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL012426-09A.1-01D	DNA	EFO	SRS2629625	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL012426-09A.1-01D SJMPAL012426_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL012426_D2	SRX3325129	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL012426-09A.1-01D SJMPAL012426_D2 run	sequencing assay	EFO	196	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL012426_D2.bam	SRR6216494	@dbgap@:reads/SRP011999/SRS2629625/SRX3325129/SRR6216494/SRR6216494.sra	2	GRCh37
TARGET-15-SJMPAL012426	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL012426-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL012426-09A.2-01D	DNA	EFO	SRS2629626	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL012426-09A.2-01D SJMPAL012426_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL012426_D3	SRX3325130	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL012426-09A.2-01D SJMPAL012426_D3 run	sequencing assay	EFO	193	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL012426_D3.bam	SRR6216495	@dbgap@:reads/SRP011999/SRS2629626/SRX3325130/SRR6216495/SRR6216495.sra	2	GRCh37
TARGET-15-SJMPAL012426	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL012426-09A.3	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL012426-09A.3-01D	DNA	EFO	SRS2629627	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL012426-09A.3-01D SJMPAL012426_D4 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL012426_D4	SRX3325131	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL012426-09A.3-01D SJMPAL012426_D4 run	sequencing assay	EFO	193	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL012426_D4.bam	SRR6216496	@dbgap@:reads/SRP011999/SRS2629627/SRX3325131/SRR6216496/SRR6216496.sra	2	GRCh37
TARGET-15-SJMPAL012426	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL012426-14A	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL012426-14A-01D	DNA	EFO	SRS1761183	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL012426-14A-01D SJMPAL012426_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL012426_G1	SRX3325132	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL012426-14A-01D SJMPAL012426_G1 run	sequencing assay	EFO	158	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL012426_G1.bam	SRR6216497	@dbgap@:reads/SRP011999/SRS1761183/SRX3325132/SRR6216497/SRR6216497.sra	2	GRCh37
TARGET-15-SJMPAL016108	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL016108-09A	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL016108-09A-01D	DNA	EFO	SRS2629628	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL016108-09A-01D SJMPAL016108_D1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL016108_D1	SRX3325133	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL016108-09A-01D SJMPAL016108_D1 run	sequencing assay	EFO	181	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL016108_D1.bam	SRR6216498	@dbgap@:reads/SRP011999/SRS2629628/SRX3325133/SRR6216498/SRR6216498.sra	2	GRCh37
TARGET-15-SJMPAL016340	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL016340-09A	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL016340-09A-01D	DNA	EFO	SRS2495555	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL016340-09A-01D SJMPAL016340_D1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL016340_D1	SRX3325134	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL016340-09A-01D SJMPAL016340_D1 run	sequencing assay	EFO	178	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL016340_D1.bam	SRR6216499	@dbgap@:reads/SRP011999/SRS2495555/SRX3325134/SRR6216499/SRR6216499.sra	2	GRCh37
TARGET-15-SJMPAL016342	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Recurrent Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL016342-04A	organism part	EFO	Bone Marrow	NCIt	"Recurrent Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL016342-04A-01D	DNA	EFO	SRS2629632	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL016342-04A-01D SJMPAL016342_R1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL016342_R1	SRX3325139	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL016342-04A-01D SJMPAL016342_R1 run	sequencing assay	EFO	186	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL016342_R1.bam	SRR6216504	@dbgap@:reads/SRP011999/SRS2629632/SRX3325139/SRR6216504/SRR6216504.sra	2	GRCh37
TARGET-15-SJMPAL016342	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL016342-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL016342-09A.1-01D	DNA	EFO	SRS2629633	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL016342-09A.1-01D SJMPAL016342_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL016342_D2	SRX3325140	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL016342-09A.1-01D SJMPAL016342_D2 run	sequencing assay	EFO	183	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL016342_D2.bam	SRR6216505	@dbgap@:reads/SRP011999/SRS2629633/SRX3325140/SRR6216505/SRR6216505.sra	2	GRCh37
TARGET-15-SJMPAL016342	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL016342-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL016342-09A.2-01D	DNA	EFO	SRS2629634	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL016342-09A.2-01D SJMPAL016342_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL016342_D3	SRX3325141	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL016342-09A.2-01D SJMPAL016342_D3 run	sequencing assay	EFO	185	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL016342_D3.bam	SRR6216506	@dbgap@:reads/SRP011999/SRS2629634/SRX3325141/SRR6216506/SRR6216506.sra	2	GRCh37
TARGET-15-SJMPAL016342	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL016342-09A.3	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL016342-09A.3-01D	DNA	EFO	SRS2629635	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL016342-09A.3-01D SJMPAL016342_D4 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL016342_D4	SRX3325142	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL016342-09A.3-01D SJMPAL016342_D4 run	sequencing assay	EFO	187	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL016342_D4.bam	SRR6216507	@dbgap@:reads/SRP011999/SRS2629635/SRX3325142/SRR6216507/SRR6216507.sra	2	GRCh37
TARGET-15-SJMPAL016342	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL016342-14A.1	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL016342-14A.1-01D	DNA	EFO	SRS1761127	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL016342-14A.1-01D SJMPAL016342_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL016342_G1	SRX3325143	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL016342-14A.1-01D SJMPAL016342_G1 run	sequencing assay	EFO	181	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL016342_G1.bam	SRR6216508	@dbgap@:reads/SRP011999/SRS1761127/SRX3325143/SRR6216508/SRR6216508.sra	2	GRCh37
TARGET-15-SJMPAL016343	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Recurrent Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL016343-04A	organism part	EFO	Bone Marrow	NCIt	"Recurrent Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL016343-04A-01D	DNA	EFO	SRS2629636	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL016343-04A-01D SJMPAL016343_R1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL016343_R1	SRX3325144	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL016343-04A-01D SJMPAL016343_R1 run	sequencing assay	EFO	154	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL016343_R1.bam	SRR6216509	@dbgap@:reads/SRP011999/SRS2629636/SRX3325144/SRR6216509/SRR6216509.sra	2	GRCh37
TARGET-15-SJMPAL016343	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL016343-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL016343-09A.1-01D	DNA	EFO	SRS2629637	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL016343-09A.1-01D SJMPAL016343_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL016343_D2	SRX3325145	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL016343-09A.1-01D SJMPAL016343_D2 run	sequencing assay	EFO	189	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL016343_D2.bam	SRR6216510	@dbgap@:reads/SRP011999/SRS2629637/SRX3325145/SRR6216510/SRR6216510.sra	2	GRCh37
TARGET-15-SJMPAL016343	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL016343-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL016343-09A.2-01D	DNA	EFO	SRS2629638	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL016343-09A.2-01D SJMPAL016343_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL016343_D3	SRX3325146	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL016343-09A.2-01D SJMPAL016343_D3 run	sequencing assay	EFO	190	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL016343_D3.bam	SRR6216511	@dbgap@:reads/SRP011999/SRS2629638/SRX3325146/SRR6216511/SRR6216511.sra	2	GRCh37
TARGET-15-SJMPAL016343	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL016343-09A.3	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL016343-09A.3-01D	DNA	EFO	SRS2629639	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL016343-09A.3-01D SJMPAL016343_D4 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL016343_D4	SRX3325147	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL016343-09A.3-01D SJMPAL016343_D4 run	sequencing assay	EFO	193	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL016343_D4.bam	SRR6216512	@dbgap@:reads/SRP011999/SRS2629639/SRX3325147/SRR6216512/SRR6216512.sra	2	GRCh37
TARGET-15-SJMPAL016343	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL016343-14A	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL016343-14A-01D	DNA	EFO	SRS2629640	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL016343-14A-01D SJMPAL016343_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL016343_G1	SRX3325148	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL016343-14A-01D SJMPAL016343_G1 run	sequencing assay	EFO	168	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL016343_G1.bam	SRR6216513	@dbgap@:reads/SRP011999/SRS2629640/SRX3325148/SRR6216513/SRR6216513.sra	2	GRCh37
TARGET-15-SJMPAL016344	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL016344-09A	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL016344-09A-01D	DNA	EFO	SRS2495559	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL016344-09A-01D SJMPAL016344_D1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL016344_D1	SRX3325149	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL016344-09A-01D SJMPAL016344_D1 run	sequencing assay	EFO	184	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL016344_D1.bam	SRR6216514	@dbgap@:reads/SRP011999/SRS2495559/SRX3325149/SRR6216514/SRR6216514.sra	2	GRCh37
TARGET-15-SJMPAL016447	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL016447-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL016447-09A.1-01D	DNA	EFO	SRS2495560	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL016447-09A.1-01D SJMPAL016447_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL016447_D2	SRX3325150	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL016447-09A.1-01D SJMPAL016447_D2 run	sequencing assay	EFO	177	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL016447_D2.bam	SRR6216515	@dbgap@:reads/SRP011999/SRS2495560/SRX3325150/SRR6216515/SRR6216515.sra	2	GRCh37
TARGET-15-SJMPAL016447	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL016447-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL016447-09A.2-01D	DNA	EFO	SRS2629642	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL016447-09A.2-01D SJMPAL016447_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL016447_D3	SRX3325151	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL016447-09A.2-01D SJMPAL016447_D3 run	sequencing assay	EFO	190	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL016447_D3.bam	SRR6216516	@dbgap@:reads/SRP011999/SRS2629642/SRX3325151/SRR6216516/SRR6216516.sra	2	GRCh37
TARGET-15-SJMPAL016447	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL016447-09A.3	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL016447-09A.3-01D	DNA	EFO	SRS2629641	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL016447-09A.3-01D SJMPAL016447_D4 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL016447_D4	SRX3325152	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL016447-09A.3-01D SJMPAL016447_D4 run	sequencing assay	EFO	181	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL016447_D4.bam	SRR6216517	@dbgap@:reads/SRP011999/SRS2629641/SRX3325152/SRR6216517/SRR6216517.sra	2	GRCh37
TARGET-15-SJMPAL016447	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL016447-14A.1	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL016447-14A.1-01D	DNA	EFO	SRS2629645	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL016447-14A.1-01D SJMPAL016447_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL016447_G1	SRX3325153	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL016447-14A.1-01D SJMPAL016447_G1 run	sequencing assay	EFO	168	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL016447_G1.bam	SRR6216518	@dbgap@:reads/SRP011999/SRS2629645/SRX3325153/SRR6216518/SRR6216518.sra	2	GRCh37
TARGET-15-SJMPAL016448	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL016448-09A	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL016448-09A-01D	DNA	EFO	SRS2495561	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL016448-09A-01D SJMPAL016448_D1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL016448_D1	SRX3325154	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL016448-09A-01D SJMPAL016448_D1 run	sequencing assay	EFO	188	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL016448_D1.bam	SRR6216519	@dbgap@:reads/SRP011999/SRS2495561/SRX3325154/SRR6216519/SRR6216519.sra	2	GRCh37
TARGET-15-SJMPAL016449	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL016449-09A	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL016449-09A-01D	DNA	EFO	SRS2629643	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL016449-09A-01D SJMPAL016449_D1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL016449_D1	SRX3325155	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL016449-09A-01D SJMPAL016449_D1 run	sequencing assay	EFO	191	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL016449_D1.bam	SRR6216520	@dbgap@:reads/SRP011999/SRS2629643/SRX3325155/SRR6216520/SRR6216520.sra	2	GRCh37
TARGET-15-SJMPAL017973	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL017973-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL017973-09A.1-01D	DNA	EFO	SRS2629644	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL017973-09A.1-01D SJMPAL017973_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL017973_D2	SRX3325156	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL017973-09A.1-01D SJMPAL017973_D2 run	sequencing assay	EFO	190	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL017973_D2.bam	SRR6216521	@dbgap@:reads/SRP011999/SRS2629644/SRX3325156/SRR6216521/SRR6216521.sra	2	GRCh37
TARGET-15-SJMPAL017973	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL017973-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL017973-09A.2-01D	DNA	EFO	SRS2629646	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL017973-09A.2-01D SJMPAL017973_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL017973_D3	SRX3325157	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL017973-09A.2-01D SJMPAL017973_D3 run	sequencing assay	EFO	193	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL017973_D3.bam	SRR6216522	@dbgap@:reads/SRP011999/SRS2629646/SRX3325157/SRR6216522/SRR6216522.sra	2	GRCh37
TARGET-15-SJMPAL017973	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL017973-14A.1	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL017973-14A.1-01D	DNA	EFO	SRS2629647	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL017973-14A.1-01D SJMPAL017973_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL017973_G1	SRX3325158	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL017973-14A.1-01D SJMPAL017973_G1 run	sequencing assay	EFO	188	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL017973_G1.bam	SRR6216523	@dbgap@:reads/SRP011999/SRS2629647/SRX3325158/SRR6216523/SRR6216523.sra	2	GRCh37
TARGET-15-SJMPAL017975	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL017975-03A.1	organism part	EFO	Peripheral Blood	NCIt	"Primary Blood Derived Cancer - Peripheral Blood"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL017975-03A.1-01D	DNA	EFO	SRS2629648	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL017975-03A.1-01D SJMPAL017975_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL017975_D2	SRX3325159	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL017975-03A.1-01D SJMPAL017975_D2 run	sequencing assay	EFO	190	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL017975_D2.bam	SRR6216524	@dbgap@:reads/SRP011999/SRS2629648/SRX3325159/SRR6216524/SRR6216524.sra	2	GRCh37
TARGET-15-SJMPAL017975	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL017975-03A.2	organism part	EFO	Peripheral Blood	NCIt	"Primary Blood Derived Cancer - Peripheral Blood"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL017975-03A.2-01D	DNA	EFO	SRS2629649	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL017975-03A.2-01D SJMPAL017975_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL017975_D3	SRX3325160	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL017975-03A.2-01D SJMPAL017975_D3 run	sequencing assay	EFO	184	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL017975_D3.bam	SRR6216525	@dbgap@:reads/SRP011999/SRS2629649/SRX3325160/SRR6216525/SRR6216525.sra	2	GRCh37
TARGET-15-SJMPAL017975	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL017975-10A.1	organism part	EFO	Peripheral Blood	NCIt	"Blood Derived Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL017975-10A.1-01D	DNA	EFO	SRS1761173	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL017975-10A.1-01D SJMPAL017975_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL017975_G1	SRX3325161	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL017975-10A.1-01D SJMPAL017975_G1 run	sequencing assay	EFO	182	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL017975_G1.bam	SRR6216526	@dbgap@:reads/SRP011999/SRS1761173/SRX3325161/SRR6216526/SRR6216526.sra	2	GRCh37
TARGET-15-SJMPAL017976	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL017976-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL017976-09A.1-01D	DNA	EFO	SRS1761122	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL017976-09A.1-01D SJMPAL017976_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL017976_D2	SRX3325162	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL017976-09A.1-01D SJMPAL017976_D2 run	sequencing assay	EFO	192	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL017976_D2.bam	SRR6216527	@dbgap@:reads/SRP011999/SRS1761122/SRX3325162/SRR6216527/SRR6216527.sra	2	GRCh37
TARGET-15-SJMPAL017976	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL017976-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL017976-09A.2-01D	DNA	EFO	SRS1761106	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL017976-09A.2-01D SJMPAL017976_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL017976_D3	SRX3325163	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL017976-09A.2-01D SJMPAL017976_D3 run	sequencing assay	EFO	202	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL017976_D3.bam	SRR6216528	@dbgap@:reads/SRP011999/SRS1761106/SRX3325163/SRR6216528/SRR6216528.sra	2	GRCh37
TARGET-15-SJMPAL017976	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL017976-09A.3	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL017976-09A.3-01D	DNA	EFO	SRS1761187	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL017976-09A.3-01D SJMPAL017976_D4 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL017976_D4	SRX3325164	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL017976-09A.3-01D SJMPAL017976_D4 run	sequencing assay	EFO	192	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL017976_D4.bam	SRR6216529	@dbgap@:reads/SRP011999/SRS1761187/SRX3325164/SRR6216529/SRR6216529.sra	2	GRCh37
TARGET-15-SJMPAL017976	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL017976-10A	organism part	EFO	Peripheral Blood	NCIt	"Blood Derived Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL017976-10A-01D	DNA	EFO	SRS1761150	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL017976-10A-01D SJMPAL017976_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL017976_G1	SRX3325165	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL017976-10A-01D SJMPAL017976_G1 run	sequencing assay	EFO	186	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL017976_G1.bam	SRR6216530	@dbgap@:reads/SRP011999/SRS1761150/SRX3325165/SRR6216530/SRR6216530.sra	2	GRCh37
TARGET-15-SJMPAL017978	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL017978-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL017978-09A.1-01D	DNA	EFO	SRS2629650	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL017978-09A.1-01D SJMPAL017978_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL017978_D2	SRX3325166	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL017978-09A.1-01D SJMPAL017978_D2 run	sequencing assay	EFO	201	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL017978_D2.bam	SRR6216531	@dbgap@:reads/SRP011999/SRS2629650/SRX3325166/SRR6216531/SRR6216531.sra	2	GRCh37
TARGET-15-SJMPAL017978	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL017978-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL017978-09A.2-01D	DNA	EFO	SRS2629651	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL017978-09A.2-01D SJMPAL017978_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL017978_D3	SRX3325167	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL017978-09A.2-01D SJMPAL017978_D3 run	sequencing assay	EFO	185	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL017978_D3.bam	SRR6216532	@dbgap@:reads/SRP011999/SRS2629651/SRX3325167/SRR6216532/SRR6216532.sra	2	GRCh37
TARGET-15-SJMPAL017978	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL017978-09A.3	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL017978-09A.3-01D	DNA	EFO	SRS2629652	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL017978-09A.3-01D SJMPAL017978_D4 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL017978_D4	SRX3325168	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL017978-09A.3-01D SJMPAL017978_D4 run	sequencing assay	EFO	199	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL017978_D4.bam	SRR6216533	@dbgap@:reads/SRP011999/SRS2629652/SRX3325168/SRR6216533/SRR6216533.sra	2	GRCh37
TARGET-15-SJMPAL017978	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL017978-14A	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL017978-14A-01D	DNA	EFO	SRS2629654	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL017978-14A-01D SJMPAL017978_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL017978_G1	SRX3325169	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL017978-14A-01D SJMPAL017978_G1 run	sequencing assay	EFO	187	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL017978_G1.bam	SRR6216534	@dbgap@:reads/SRP011999/SRS2629654/SRX3325169/SRR6216534/SRR6216534.sra	2	GRCh37
TARGET-15-SJMPAL017979	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL017979-09A	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL017979-09A-01D	DNA	EFO	SRS2629653	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL017979-09A-01D SJMPAL017979_D1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL017979_D1	SRX3325170	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL017979-09A-01D SJMPAL017979_D1 run	sequencing assay	EFO	176	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL017979_D1.bam	SRR6216535	@dbgap@:reads/SRP011999/SRS2629653/SRX3325170/SRR6216535/SRR6216535.sra	2	GRCh37
TARGET-15-SJMPAL017981	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL017981-03A.1	organism part	EFO	Peripheral Blood	NCIt	"Primary Blood Derived Cancer - Peripheral Blood"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL017981-03A.1-01D	DNA	EFO	SRS2629656	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL017981-03A.1-01D SJMPAL017981_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL017981_D2	SRX3325171	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL017981-03A.1-01D SJMPAL017981_D2 run	sequencing assay	EFO	175	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL017981_D2.bam	SRR6216536	@dbgap@:reads/SRP011999/SRS2629656/SRX3325171/SRR6216536/SRR6216536.sra	2	GRCh37
TARGET-15-SJMPAL017981	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL017981-03A.2	organism part	EFO	Peripheral Blood	NCIt	"Primary Blood Derived Cancer - Peripheral Blood"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL017981-03A.2-01D	DNA	EFO	SRS2629655	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL017981-03A.2-01D SJMPAL017981_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL017981_D3	SRX3325172	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL017981-03A.2-01D SJMPAL017981_D3 run	sequencing assay	EFO	190	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL017981_D3.bam	SRR6216537	@dbgap@:reads/SRP011999/SRS2629655/SRX3325172/SRR6216537/SRR6216537.sra	2	GRCh37
TARGET-15-SJMPAL017981	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL017981-03A.3	organism part	EFO	Peripheral Blood	NCIt	"Primary Blood Derived Cancer - Peripheral Blood"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL017981-03A.3-01D	DNA	EFO	SRS2629657	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL017981-03A.3-01D SJMPAL017981_D4 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL017981_D4	SRX3325173	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL017981-03A.3-01D SJMPAL017981_D4 run	sequencing assay	EFO	201	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL017981_D4.bam	SRR6216538	@dbgap@:reads/SRP011999/SRS2629657/SRX3325173/SRR6216538/SRR6216538.sra	2	GRCh37
TARGET-15-SJMPAL017981	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL017981-10A	organism part	EFO	Peripheral Blood	NCIt	"Blood Derived Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL017981-10A-01D	DNA	EFO	SRS2629717	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL017981-10A-01D SJMPAL017981_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL017981_G1	SRX3325174	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL017981-10A-01D SJMPAL017981_G1 run	sequencing assay	EFO	190	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL017981_G1.bam	SRR6216539	@dbgap@:reads/SRP011999/SRS2629717/SRX3325174/SRR6216539/SRR6216539.sra	2	GRCh37
TARGET-15-SJMPAL040024	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL040024-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040024-09A.1-01D	DNA	EFO	SRS2629660	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040024-09A.1-01D SJMPAL040024_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040024_D2	SRX3325175	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040024-09A.1-01D SJMPAL040024_D2 run	sequencing assay	EFO	191	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040024_D2.bam	SRR6216540	@dbgap@:reads/SRP011999/SRS2629660/SRX3325175/SRR6216540/SRR6216540.sra	2	GRCh37
TARGET-15-SJMPAL040024	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL040024-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040024-09A.2-01D	DNA	EFO	SRS2629659	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040024-09A.2-01D SJMPAL040024_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040024_D3	SRX3325176	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040024-09A.2-01D SJMPAL040024_D3 run	sequencing assay	EFO	186	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040024_D3.bam	SRR6216541	@dbgap@:reads/SRP011999/SRS2629659/SRX3325176/SRR6216541/SRR6216541.sra	2	GRCh37
TARGET-15-SJMPAL040024	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL040024-14A.1	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040024-14A.1-01D	DNA	EFO	SRS2629658	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040024-14A.1-01D SJMPAL040024_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040024_G1	SRX3325177	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040024-14A.1-01D SJMPAL040024_G1 run	sequencing assay	EFO	191	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040024_G1.bam	SRR6216542	@dbgap@:reads/SRP011999/SRS2629658/SRX3325177/SRR6216542/SRR6216542.sra	2	GRCh37
TARGET-15-SJMPAL040025	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL040025-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040025-09A.1-01D	DNA	EFO	SRS2629661	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040025-09A.1-01D SJMPAL040025_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040025_D2	SRX3325178	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040025-09A.1-01D SJMPAL040025_D2 run	sequencing assay	EFO	200	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040025_D2.bam	SRR6216543	@dbgap@:reads/SRP011999/SRS2629661/SRX3325178/SRR6216543/SRR6216543.sra	2	GRCh37
TARGET-15-SJMPAL040025	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL040025-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040025-09A.2-01D	DNA	EFO	SRS2629662	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040025-09A.2-01D SJMPAL040025_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040025_D3	SRX3325179	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040025-09A.2-01D SJMPAL040025_D3 run	sequencing assay	EFO	201	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040025_D3.bam	SRR6216544	@dbgap@:reads/SRP011999/SRS2629662/SRX3325179/SRR6216544/SRR6216544.sra	2	GRCh37
TARGET-15-SJMPAL040025	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL040025-14A.1	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040025-14A.1-01D	DNA	EFO	SRS1761124	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040025-14A.1-01D SJMPAL040025_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040025_G1	SRX3325180	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040025-14A.1-01D SJMPAL040025_G1 run	sequencing assay	EFO	200	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040025_G1.bam	SRR6216545	@dbgap@:reads/SRP011999/SRS1761124/SRX3325180/SRR6216545/SRR6216545.sra	2	GRCh37
TARGET-15-SJMPAL040026	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL040026-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040026-09A.1-01D	DNA	EFO	SRS2629663	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040026-09A.1-01D SJMPAL040026_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040026_D2	SRX3325181	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040026-09A.1-01D SJMPAL040026_D2 run	sequencing assay	EFO	194	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040026_D2.bam	SRR6216546	@dbgap@:reads/SRP011999/SRS2629663/SRX3325181/SRR6216546/SRR6216546.sra	2	GRCh37
TARGET-15-SJMPAL040026	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL040026-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040026-09A.2-01D	DNA	EFO	SRS2629664	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040026-09A.2-01D SJMPAL040026_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040026_D3	SRX3325182	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040026-09A.2-01D SJMPAL040026_D3 run	sequencing assay	EFO	192	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040026_D3.bam	SRR6216547	@dbgap@:reads/SRP011999/SRS2629664/SRX3325182/SRR6216547/SRR6216547.sra	2	GRCh37
TARGET-15-SJMPAL040026	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL040026-09A.3	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040026-09A.3-01D	DNA	EFO	SRS2629665	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040026-09A.3-01D SJMPAL040026_D4 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040026_D4	SRX3325183	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040026-09A.3-01D SJMPAL040026_D4 run	sequencing assay	EFO	189	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040026_D4.bam	SRR6216548	@dbgap@:reads/SRP011999/SRS2629665/SRX3325183/SRR6216548/SRR6216548.sra	2	GRCh37
TARGET-15-SJMPAL040027	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL040027-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040027-09A.1-01D	DNA	EFO	SRS2629666	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040027-09A.1-01D SJMPAL040027_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040027_D2	SRX3325184	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040027-09A.1-01D SJMPAL040027_D2 run	sequencing assay	EFO	191	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040027_D2.bam	SRR6216549	@dbgap@:reads/SRP011999/SRS2629666/SRX3325184/SRR6216549/SRR6216549.sra	2	GRCh37
TARGET-15-SJMPAL040027	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL040027-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040027-09A.2-01D	DNA	EFO	SRS2629668	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040027-09A.2-01D SJMPAL040027_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040027_D3	SRX3325185	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040027-09A.2-01D SJMPAL040027_D3 run	sequencing assay	EFO	191	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040027_D3.bam	SRR6216550	@dbgap@:reads/SRP011999/SRS2629668/SRX3325185/SRR6216550/SRR6216550.sra	2	GRCh37
TARGET-15-SJMPAL040027	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL040027-09A.3	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040027-09A.3-01D	DNA	EFO	SRS2629667	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040027-09A.3-01D SJMPAL040027_D4 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040027_D4	SRX3325186	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040027-09A.3-01D SJMPAL040027_D4 run	sequencing assay	EFO	196	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040027_D4.bam	SRR6216551	@dbgap@:reads/SRP011999/SRS2629667/SRX3325186/SRR6216551/SRR6216551.sra	2	GRCh37
TARGET-15-SJMPAL040027	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL040027-14A	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040027-14A-01D	DNA	EFO	SRS2629669	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040027-14A-01D SJMPAL040027_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040027_G1	SRX3325187	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040027-14A-01D SJMPAL040027_G1 run	sequencing assay	EFO	178	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040027_G1.bam	SRR6216552	@dbgap@:reads/SRP011999/SRS2629669/SRX3325187/SRR6216552/SRR6216552.sra	2	GRCh37
TARGET-15-SJMPAL040028	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Recurrent Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL040028-04A.1	organism part	EFO	Bone Marrow	NCIt	"Recurrent Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040028-04A.1-01D	DNA	EFO	SRS1761128	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040028-04A.1-01D SJMPAL040028_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040028_D2	SRX3325188	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040028-04A.1-01D SJMPAL040028_D2 run	sequencing assay	EFO	194	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040028_D2.bam	SRR6216553	@dbgap@:reads/SRP011999/SRS1761128/SRX3325188/SRR6216553/SRR6216553.sra	2	GRCh37
TARGET-15-SJMPAL040028	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Recurrent Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL040028-04A.2	organism part	EFO	Bone Marrow	NCIt	"Recurrent Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040028-04A.2-01D	DNA	EFO	SRS1761139	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040028-04A.2-01D SJMPAL040028_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040028_D3	SRX3325189	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040028-04A.2-01D SJMPAL040028_D3 run	sequencing assay	EFO	193	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040028_D3.bam	SRR6216554	@dbgap@:reads/SRP011999/SRS1761139/SRX3325189/SRR6216554/SRR6216554.sra	2	GRCh37
TARGET-15-SJMPAL040028	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Recurrent Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL040028-04A.3	organism part	EFO	Bone Marrow	NCIt	"Recurrent Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040028-04A.3-01D	DNA	EFO	SRS1761151	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040028-04A.3-01D SJMPAL040028_D4 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040028_D4	SRX3325190	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040028-04A.3-01D SJMPAL040028_D4 run	sequencing assay	EFO	189	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040028_D4.bam	SRR6216555	@dbgap@:reads/SRP011999/SRS1761151/SRX3325190/SRR6216555/SRR6216555.sra	2	GRCh37
TARGET-15-SJMPAL040028	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL040028-14A.1	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040028-14A.1-01D	DNA	EFO	SRS1761140	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040028-14A.1-01D SJMPAL040028_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040028_G1	SRX3325191	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040028-14A.1-01D SJMPAL040028_G1 run	sequencing assay	EFO	192	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040028_G1.bam	SRR6216556	@dbgap@:reads/SRP011999/SRS1761140/SRX3325191/SRR6216556/SRR6216556.sra	2	GRCh37
TARGET-15-SJMPAL040030	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL040030-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040030-09A.1-01D	DNA	EFO	SRS2629670	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040030-09A.1-01D SJMPAL040030_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040030_D2	SRX3325192	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040030-09A.1-01D SJMPAL040030_D2 run	sequencing assay	EFO	191	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040030_D2.bam	SRR6216557	@dbgap@:reads/SRP011999/SRS2629670/SRX3325192/SRR6216557/SRR6216557.sra	2	GRCh37
TARGET-15-SJMPAL040030	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL040030-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040030-09A.2-01D	DNA	EFO	SRS2629671	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040030-09A.2-01D SJMPAL040030_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040030_D3	SRX3325193	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040030-09A.2-01D SJMPAL040030_D3 run	sequencing assay	EFO	186	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040030_D3.bam	SRR6216558	@dbgap@:reads/SRP011999/SRS2629671/SRX3325193/SRR6216558/SRR6216558.sra	2	GRCh37
TARGET-15-SJMPAL040030	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL040030-09A.3	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040030-09A.3-01D	DNA	EFO	SRS2629676	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040030-09A.3-01D SJMPAL040030_D4 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040030_D4	SRX3325194	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040030-09A.3-01D SJMPAL040030_D4 run	sequencing assay	EFO	185	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040030_D4.bam	SRR6216559	@dbgap@:reads/SRP011999/SRS2629676/SRX3325194/SRR6216559/SRR6216559.sra	2	GRCh37
TARGET-15-SJMPAL040030	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL040030-09A.4	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040030-09A.4-01D	DNA	EFO	SRS2629672	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040030-09A.4-01D SJMPAL040030_D5 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040030_D5	SRX3325195	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040030-09A.4-01D SJMPAL040030_D5 run	sequencing assay	EFO	195	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040030_D5.bam	SRR6216560	@dbgap@:reads/SRP011999/SRS2629672/SRX3325195/SRR6216560/SRR6216560.sra	2	GRCh37
TARGET-15-SJMPAL040030	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL040030-14A	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040030-14A-01D	DNA	EFO	SRS2629673	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040030-14A-01D SJMPAL040030_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040030_G1	SRX3325196	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040030-14A-01D SJMPAL040030_G1 run	sequencing assay	EFO	172	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040030_G1.bam	SRR6216561	@dbgap@:reads/SRP011999/SRS2629673/SRX3325196/SRR6216561/SRR6216561.sra	2	GRCh37
TARGET-15-SJMPAL040031	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL040031-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040031-09A.1-01D	DNA	EFO	SRS2629674	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040031-09A.1-01D SJMPAL040031_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040031_D2	SRX3325197	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040031-09A.1-01D SJMPAL040031_D2 run	sequencing assay	EFO	190	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040031_D2.bam	SRR6216562	@dbgap@:reads/SRP011999/SRS2629674/SRX3325197/SRR6216562/SRR6216562.sra	2	GRCh37
TARGET-15-SJMPAL040031	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL040031-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040031-09A.2-01D	DNA	EFO	SRS2629675	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040031-09A.2-01D SJMPAL040031_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040031_D3	SRX3325198	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040031-09A.2-01D SJMPAL040031_D3 run	sequencing assay	EFO	192	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040031_D3.bam	SRR6216563	@dbgap@:reads/SRP011999/SRS2629675/SRX3325198/SRR6216563/SRR6216563.sra	2	GRCh37
TARGET-15-SJMPAL040031	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL040031-09A.3	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040031-09A.3-01D	DNA	EFO	SRS2629678	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040031-09A.3-01D SJMPAL040031_D4 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040031_D4	SRX3325199	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040031-09A.3-01D SJMPAL040031_D4 run	sequencing assay	EFO	195	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040031_D4.bam	SRR6216564	@dbgap@:reads/SRP011999/SRS2629678/SRX3325199/SRR6216564/SRR6216564.sra	2	GRCh37
TARGET-15-SJMPAL040031	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL040031-09A.4	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040031-09A.4-01D	DNA	EFO	SRS2629677	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040031-09A.4-01D SJMPAL040031_D5 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040031_D5	SRX3325200	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040031-09A.4-01D SJMPAL040031_D5 run	sequencing assay	EFO	190	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040031_D5.bam	SRR6216565	@dbgap@:reads/SRP011999/SRS2629677/SRX3325200/SRR6216565/SRR6216565.sra	2	GRCh37
TARGET-15-SJMPAL040031	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL040031-14A	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040031-14A-01D	DNA	EFO	SRS2629679	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040031-14A-01D SJMPAL040031_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040031_G1	SRX3325201	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040031-14A-01D SJMPAL040031_G1 run	sequencing assay	EFO	182	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040031_G1.bam	SRR6216566	@dbgap@:reads/SRP011999/SRS2629679/SRX3325201/SRR6216566/SRR6216566.sra	2	GRCh37
TARGET-15-SJMPAL040032	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL040032-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040032-09A.1-01D	DNA	EFO	SRS2629682	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040032-09A.1-01D SJMPAL040032_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040032_D2	SRX3325202	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040032-09A.1-01D SJMPAL040032_D2 run	sequencing assay	EFO	184	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040032_D2.bam	SRR6216567	@dbgap@:reads/SRP011999/SRS2629682/SRX3325202/SRR6216567/SRR6216567.sra	2	GRCh37
TARGET-15-SJMPAL040032	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL040032-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040032-09A.2-01D	DNA	EFO	SRS2629680	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040032-09A.2-01D SJMPAL040032_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040032_D3	SRX3325203	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040032-09A.2-01D SJMPAL040032_D3 run	sequencing assay	EFO	191	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040032_D3.bam	SRR6216568	@dbgap@:reads/SRP011999/SRS2629680/SRX3325203/SRR6216568/SRR6216568.sra	2	GRCh37
TARGET-15-SJMPAL040032	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL040032-09A.3	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040032-09A.3-01D	DNA	EFO	SRS2629681	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040032-09A.3-01D SJMPAL040032_D4 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040032_D4	SRX3325204	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040032-09A.3-01D SJMPAL040032_D4 run	sequencing assay	EFO	185	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040032_D4.bam	SRR6216569	@dbgap@:reads/SRP011999/SRS2629681/SRX3325204/SRR6216569/SRR6216569.sra	2	GRCh37
TARGET-15-SJMPAL040032	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL040032-14A.1	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040032-14A.1-01D	DNA	EFO	SRS1761166	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040032-14A.1-01D SJMPAL040032_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040032_G1	SRX3325205	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040032-14A.1-01D SJMPAL040032_G1 run	sequencing assay	EFO	193	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040032_G1.bam	SRR6216570	@dbgap@:reads/SRP011999/SRS1761166/SRX3325205/SRR6216570/SRR6216570.sra	2	GRCh37
TARGET-15-SJMPAL040033	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL040033-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040033-09A.1-01D	DNA	EFO	SRS2629683	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040033-09A.1-01D SJMPAL040033_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040033_D2	SRX3325206	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040033-09A.1-01D SJMPAL040033_D2 run	sequencing assay	EFO	182	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040033_D2.bam	SRR6216571	@dbgap@:reads/SRP011999/SRS2629683/SRX3325206/SRR6216571/SRR6216571.sra	2	GRCh37
TARGET-15-SJMPAL040033	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL040033-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040033-09A.2-01D	DNA	EFO	SRS2629684	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040033-09A.2-01D SJMPAL040033_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040033_D3	SRX3325207	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040033-09A.2-01D SJMPAL040033_D3 run	sequencing assay	EFO	195	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040033_D3.bam	SRR6216572	@dbgap@:reads/SRP011999/SRS2629684/SRX3325207/SRR6216572/SRR6216572.sra	2	GRCh37
TARGET-15-SJMPAL040033	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL040033-09A.3	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040033-09A.3-01D	DNA	EFO	SRS2629685	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040033-09A.3-01D SJMPAL040033_D4 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040033_D4	SRX3325208	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040033-09A.3-01D SJMPAL040033_D4 run	sequencing assay	EFO	194	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040033_D4.bam	SRR6216573	@dbgap@:reads/SRP011999/SRS2629685/SRX3325208/SRR6216573/SRR6216573.sra	2	GRCh37
TARGET-15-SJMPAL040033	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL040033-14A.1	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040033-14A.1-01D	DNA	EFO	SRS2629687	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040033-14A.1-01D SJMPAL040033_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040033_G1	SRX3325209	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040033-14A.1-01D SJMPAL040033_G1 run	sequencing assay	EFO	190	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040033_G1.bam	SRR6216574	@dbgap@:reads/SRP011999/SRS2629687/SRX3325209/SRR6216574/SRR6216574.sra	2	GRCh37
TARGET-15-SJMPAL040034	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL040034-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040034-09A.1-01D	DNA	EFO	SRS2629686	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040034-09A.1-01D SJMPAL040034_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040034_D2	SRX3325210	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040034-09A.1-01D SJMPAL040034_D2 run	sequencing assay	EFO	188	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040034_D2.bam	SRR6216575	@dbgap@:reads/SRP011999/SRS2629686/SRX3325210/SRR6216575/SRR6216575.sra	2	GRCh37
TARGET-15-SJMPAL040034	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL040034-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040034-09A.2-01D	DNA	EFO	SRS2629688	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040034-09A.2-01D SJMPAL040034_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040034_D3	SRX3325211	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040034-09A.2-01D SJMPAL040034_D3 run	sequencing assay	EFO	191	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040034_D3.bam	SRR6216576	@dbgap@:reads/SRP011999/SRS2629688/SRX3325211/SRR6216576/SRR6216576.sra	2	GRCh37
TARGET-15-SJMPAL040034	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL040034-14A	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040034-14A-01D	DNA	EFO	SRS2629689	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040034-14A-01D SJMPAL040034_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040034_G1	SRX3325212	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040034-14A-01D SJMPAL040034_G1 run	sequencing assay	EFO	156	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040034_G1.bam	SRR6216577	@dbgap@:reads/SRP011999/SRS2629689/SRX3325212/SRR6216577/SRR6216577.sra	2	GRCh37
TARGET-15-SJMPAL040035	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL040035-03A.1	organism part	EFO	Peripheral Blood	NCIt	"Primary Blood Derived Cancer - Peripheral Blood"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040035-03A.1-01D	DNA	EFO	SRS2629738	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040035-03A.1-01D SJMPAL040035_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040035_D2	SRX3325213	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040035-03A.1-01D SJMPAL040035_D2 run	sequencing assay	EFO	189	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040035_D2.bam	SRR6216578	@dbgap@:reads/SRP011999/SRS2629738/SRX3325213/SRR6216578/SRR6216578.sra	2	GRCh37
TARGET-15-SJMPAL040035	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL040035-03A.2	organism part	EFO	Peripheral Blood	NCIt	"Primary Blood Derived Cancer - Peripheral Blood"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040035-03A.2-01D	DNA	EFO	SRS2629690	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040035-03A.2-01D SJMPAL040035_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040035_D3	SRX3325214	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040035-03A.2-01D SJMPAL040035_D3 run	sequencing assay	EFO	188	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040035_D3.bam	SRR6216579	@dbgap@:reads/SRP011999/SRS2629690/SRX3325214/SRR6216579/SRR6216579.sra	2	GRCh37
TARGET-15-SJMPAL040035	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL040035-14A	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040035-14A-01D	DNA	EFO	SRS2629691	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040035-14A-01D SJMPAL040035_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040035_G1	SRX3325215	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040035-14A-01D SJMPAL040035_G1 run	sequencing assay	EFO	178	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040035_G1.bam	SRR6216580	@dbgap@:reads/SRP011999/SRS2629691/SRX3325215/SRR6216580/SRR6216580.sra	2	GRCh37
TARGET-15-SJMPAL040036	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL040036-03A.1	organism part	EFO	Peripheral Blood	NCIt	"Primary Blood Derived Cancer - Peripheral Blood"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040036-03A.1-01D	DNA	EFO	SRS1761190	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040036-03A.1-01D SJMPAL040036_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040036_D2	SRX3325216	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040036-03A.1-01D SJMPAL040036_D2 run	sequencing assay	EFO	193	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040036_D2.bam	SRR6216581	@dbgap@:reads/SRP011999/SRS1761190/SRX3325216/SRR6216581/SRR6216581.sra	2	GRCh37
TARGET-15-SJMPAL040036	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL040036-03A.2	organism part	EFO	Peripheral Blood	NCIt	"Primary Blood Derived Cancer - Peripheral Blood"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040036-03A.2-01D	DNA	EFO	SRS1761104	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040036-03A.2-01D SJMPAL040036_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040036_D3	SRX3325217	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040036-03A.2-01D SJMPAL040036_D3 run	sequencing assay	EFO	192	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040036_D3.bam	SRR6216582	@dbgap@:reads/SRP011999/SRS1761104/SRX3325217/SRR6216582/SRR6216582.sra	2	GRCh37
TARGET-15-SJMPAL040036	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL040036-03A.3	organism part	EFO	Peripheral Blood	NCIt	"Primary Blood Derived Cancer - Peripheral Blood"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040036-03A.3-01D	DNA	EFO	SRS1761155	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040036-03A.3-01D SJMPAL040036_D4 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040036_D4	SRX3325218	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040036-03A.3-01D SJMPAL040036_D4 run	sequencing assay	EFO	190	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040036_D4.bam	SRR6216583	@dbgap@:reads/SRP011999/SRS1761155/SRX3325218/SRR6216583/SRR6216583.sra	2	GRCh37
TARGET-15-SJMPAL040036	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL040036-03A.4	organism part	EFO	Peripheral Blood	NCIt	"Primary Blood Derived Cancer - Peripheral Blood"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040036-03A.4-01D	DNA	EFO	SRS1761194	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040036-03A.4-01D SJMPAL040036_D5 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040036_D5	SRX3325219	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040036-03A.4-01D SJMPAL040036_D5 run	sequencing assay	EFO	201	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040036_D5.bam	SRR6216584	@dbgap@:reads/SRP011999/SRS1761194/SRX3325219/SRR6216584/SRR6216584.sra	2	GRCh37
TARGET-15-SJMPAL040036	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL040036-14A	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040036-14A-01D	DNA	EFO	SRS1761189	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040036-14A-01D SJMPAL040036_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040036_G1	SRX3325220	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040036-14A-01D SJMPAL040036_G1 run	sequencing assay	EFO	182	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040036_G1.bam	SRR6216585	@dbgap@:reads/SRP011999/SRS1761189/SRX3325220/SRR6216585/SRR6216585.sra	2	GRCh37
TARGET-15-SJMPAL040037	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL040037-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040037-09A.1-01D	DNA	EFO	SRS2629744	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040037-09A.1-01D SJMPAL040037_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040037_D2	SRX3325221	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040037-09A.1-01D SJMPAL040037_D2 run	sequencing assay	EFO	192	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040037_D2.bam	SRR6216586	@dbgap@:reads/SRP011999/SRS2629744/SRX3325221/SRR6216586/SRR6216586.sra	2	GRCh37
TARGET-15-SJMPAL040037	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL040037-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040037-09A.2-01D	DNA	EFO	SRS2629692	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040037-09A.2-01D SJMPAL040037_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040037_D3	SRX3325222	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040037-09A.2-01D SJMPAL040037_D3 run	sequencing assay	EFO	194	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040037_D3.bam	SRR6216587	@dbgap@:reads/SRP011999/SRS2629692/SRX3325222/SRR6216587/SRR6216587.sra	2	GRCh37
TARGET-15-SJMPAL040037	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL040037-09A.3	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040037-09A.3-01D	DNA	EFO	SRS2629693	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040037-09A.3-01D SJMPAL040037_D4 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040037_D4	SRX3325223	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040037-09A.3-01D SJMPAL040037_D4 run	sequencing assay	EFO	187	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040037_D4.bam	SRR6216588	@dbgap@:reads/SRP011999/SRS2629693/SRX3325223/SRR6216588/SRR6216588.sra	2	GRCh37
TARGET-15-SJMPAL040037	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL040037-09A.4	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040037-09A.4-01D	DNA	EFO	SRS2629694	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040037-09A.4-01D SJMPAL040037_D5 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040037_D5	SRX3325224	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040037-09A.4-01D SJMPAL040037_D5 run	sequencing assay	EFO	195	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040037_D5.bam	SRR6216589	@dbgap@:reads/SRP011999/SRS2629694/SRX3325224/SRR6216589/SRR6216589.sra	2	GRCh37
TARGET-15-SJMPAL040037	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL040037-14A	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040037-14A-01D	DNA	EFO	SRS1761161	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040037-14A-01D SJMPAL040037_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040037_G1	SRX3325225	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040037-14A-01D SJMPAL040037_G1 run	sequencing assay	EFO	184	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040037_G1.bam	SRR6216590	@dbgap@:reads/SRP011999/SRS1761161/SRX3325225/SRR6216590/SRR6216590.sra	2	GRCh37
TARGET-15-SJMPAL040038	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL040038-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040038-09A.1-01D	DNA	EFO	SRS1761170	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040038-09A.1-01D SJMPAL040038_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040038_D2	SRX3325226	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040038-09A.1-01D SJMPAL040038_D2 run	sequencing assay	EFO	191	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040038_D2.bam	SRR6216591	@dbgap@:reads/SRP011999/SRS1761170/SRX3325226/SRR6216591/SRR6216591.sra	2	GRCh37
TARGET-15-SJMPAL040038	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL040038-14A	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040038-14A-01D	DNA	EFO	SRS1761167	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040038-14A-01D SJMPAL040038_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040038_G1	SRX3325227	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040038-14A-01D SJMPAL040038_G1 run	sequencing assay	EFO	189	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040038_G1.bam	SRR6216592	@dbgap@:reads/SRP011999/SRS1761167/SRX3325227/SRR6216592/SRR6216592.sra	2	GRCh37
TARGET-15-SJMPAL040039	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL040039-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040039-09A.1-01D	DNA	EFO	SRS2629695	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040039-09A.1-01D SJMPAL040039_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040039_D2	SRX3325228	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040039-09A.1-01D SJMPAL040039_D2 run	sequencing assay	EFO	195	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040039_D2.bam	SRR6216593	@dbgap@:reads/SRP011999/SRS2629695/SRX3325228/SRR6216593/SRR6216593.sra	2	GRCh37
TARGET-15-SJMPAL040039	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL040039-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040039-09A.2-01D	DNA	EFO	SRS1761186	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040039-09A.2-01D SJMPAL040039_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040039_D3	SRX3325229	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040039-09A.2-01D SJMPAL040039_D3 run	sequencing assay	EFO	192	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040039_D3.bam	SRR6216594	@dbgap@:reads/SRP011999/SRS1761186/SRX3325229/SRR6216594/SRR6216594.sra	2	GRCh37
TARGET-15-SJMPAL040039	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL040039-14A	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040039-14A-01D	DNA	EFO	SRS1761172	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040039-14A-01D SJMPAL040039_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040039_G1	SRX3325230	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040039-14A-01D SJMPAL040039_G1 run	sequencing assay	EFO	185	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040039_G1.bam	SRR6216595	@dbgap@:reads/SRP011999/SRS1761172/SRX3325230/SRR6216595/SRR6216595.sra	2	GRCh37
TARGET-15-SJMPAL040459	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL040459-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040459-09A.1-01D	DNA	EFO	SRS2629696	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040459-09A.1-01D SJMPAL040459_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040459_D2	SRX3325231	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040459-09A.1-01D SJMPAL040459_D2 run	sequencing assay	EFO	165	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040459_D2.bam	SRR6216596	@dbgap@:reads/SRP011999/SRS2629696/SRX3325231/SRR6216596/SRR6216596.sra	2	GRCh37
TARGET-15-SJMPAL040459	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL040459-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040459-09A.2-01D	DNA	EFO	SRS2629697	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040459-09A.2-01D SJMPAL040459_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040459_D3	SRX3325232	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040459-09A.2-01D SJMPAL040459_D3 run	sequencing assay	EFO	195	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040459_D3.bam	SRR6216597	@dbgap@:reads/SRP011999/SRS2629697/SRX3325232/SRR6216597/SRR6216597.sra	2	GRCh37
TARGET-15-SJMPAL040459	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL040459-09A.3	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL040459-09A.3-01D	DNA	EFO	SRS2629698	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL040459-09A.3-01D SJMPAL040459_D4 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL040459_D4	SRX3325233	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL040459-09A.3-01D SJMPAL040459_D4 run	sequencing assay	EFO	194	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL040459_D4.bam	SRR6216598	@dbgap@:reads/SRP011999/SRS2629698/SRX3325233/SRR6216598/SRR6216598.sra	2	GRCh37
TARGET-15-SJMPAL041117	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL041117-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL041117-09A.1-01D	DNA	EFO	SRS2629699	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL041117-09A.1-01D SJMPAL041117_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL041117_D2	SRX3325234	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL041117-09A.1-01D SJMPAL041117_D2 run	sequencing assay	EFO	191	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL041117_D2.bam	SRR6216599	@dbgap@:reads/SRP011999/SRS2629699/SRX3325234/SRR6216599/SRR6216599.sra	2	GRCh37
TARGET-15-SJMPAL041117	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL041117-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL041117-09A.2-01D	DNA	EFO	SRS2629700	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL041117-09A.2-01D SJMPAL041117_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL041117_D3	SRX3325235	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL041117-09A.2-01D SJMPAL041117_D3 run	sequencing assay	EFO	202	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL041117_D3.bam	SRR6216600	@dbgap@:reads/SRP011999/SRS2629700/SRX3325235/SRR6216600/SRR6216600.sra	2	GRCh37
TARGET-15-SJMPAL041117	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL041117-14A	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL041117-14A-01D	DNA	EFO	SRS1761205	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL041117-14A-01D SJMPAL041117_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL041117_G1	SRX3325236	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL041117-14A-01D SJMPAL041117_G1 run	sequencing assay	EFO	187	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL041117_G1.bam	SRR6216601	@dbgap@:reads/SRP011999/SRS1761205/SRX3325236/SRR6216601/SRR6216601.sra	2	GRCh37
TARGET-15-SJMPAL041118	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL041118-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL041118-09A.1-01D	DNA	EFO	SRS2629701	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL041118-09A.1-01D SJMPAL041118_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL041118_D2	SRX3325237	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL041118-09A.1-01D SJMPAL041118_D2 run	sequencing assay	EFO	200	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL041118_D2.bam	SRR6216602	@dbgap@:reads/SRP011999/SRS2629701/SRX3325237/SRR6216602/SRR6216602.sra	2	GRCh37
TARGET-15-SJMPAL041118	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL041118-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL041118-09A.2-01D	DNA	EFO	SRS2629702	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL041118-09A.2-01D SJMPAL041118_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL041118_D3	SRX3325238	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL041118-09A.2-01D SJMPAL041118_D3 run	sequencing assay	EFO	202	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL041118_D3.bam	SRR6216603	@dbgap@:reads/SRP011999/SRS2629702/SRX3325238/SRR6216603/SRR6216603.sra	2	GRCh37
TARGET-15-SJMPAL041118	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL041118-09A.3	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL041118-09A.3-01D	DNA	EFO	SRS2629703	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL041118-09A.3-01D SJMPAL041118_D4 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL041118_D4	SRX3325239	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL041118-09A.3-01D SJMPAL041118_D4 run	sequencing assay	EFO	198	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL041118_D4.bam	SRR6216604	@dbgap@:reads/SRP011999/SRS2629703/SRX3325239/SRR6216604/SRR6216604.sra	2	GRCh37
TARGET-15-SJMPAL041118	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL041118-14A	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL041118-14A-01D	DNA	EFO	SRS2629704	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL041118-14A-01D SJMPAL041118_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL041118_G1	SRX3325240	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL041118-14A-01D SJMPAL041118_G1 run	sequencing assay	EFO	193	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL041118_G1.bam	SRR6216605	@dbgap@:reads/SRP011999/SRS2629704/SRX3325240/SRR6216605/SRR6216605.sra	2	GRCh37
TARGET-15-SJMPAL041119	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL041119-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL041119-09A.1-01D	DNA	EFO	SRS2629705	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL041119-09A.1-01D SJMPAL041119_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL041119_D2	SRX3325241	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL041119-09A.1-01D SJMPAL041119_D2 run	sequencing assay	EFO	202	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL041119_D2.bam	SRR6216606	@dbgap@:reads/SRP011999/SRS2629705/SRX3325241/SRR6216606/SRR6216606.sra	2	GRCh37
TARGET-15-SJMPAL041119	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL041119-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL041119-09A.2-01D	DNA	EFO	SRS2629706	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL041119-09A.2-01D SJMPAL041119_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL041119_D3	SRX3325242	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL041119-09A.2-01D SJMPAL041119_D3 run	sequencing assay	EFO	202	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL041119_D3.bam	SRR6216607	@dbgap@:reads/SRP011999/SRS2629706/SRX3325242/SRR6216607/SRR6216607.sra	2	GRCh37
TARGET-15-SJMPAL041119	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL041119-14A	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL041119-14A-01D	DNA	EFO	SRS1761114	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL041119-14A-01D SJMPAL041119_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL041119_G1	SRX3325243	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL041119-14A-01D SJMPAL041119_G1 run	sequencing assay	EFO	181	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL041119_G1.bam	SRR6216608	@dbgap@:reads/SRP011999/SRS1761114/SRX3325243/SRR6216608/SRR6216608.sra	2	GRCh37
TARGET-15-SJMPAL041120	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL041120-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL041120-09A.1-01D	DNA	EFO	SRS2629707	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL041120-09A.1-01D SJMPAL041120_D5 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL041120_D5	SRX3325244	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL041120-09A.1-01D SJMPAL041120_D5 run	sequencing assay	EFO	189	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL041120_D5.bam	SRR6216609	@dbgap@:reads/SRP011999/SRS2629707/SRX3325244/SRR6216609/SRR6216609.sra	2	GRCh37
TARGET-15-SJMPAL041120	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL041120-14A	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL041120-14A-01D	DNA	EFO	SRS1761178	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL041120-14A-01D SJMPAL041120_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL041120_G1	SRX3325245	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL041120-14A-01D SJMPAL041120_G1 run	sequencing assay	EFO	195	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL041120_G1.bam	SRR6216610	@dbgap@:reads/SRP011999/SRS1761178/SRX3325245/SRR6216610/SRR6216610.sra	2	GRCh37
TARGET-15-SJMPAL041121	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL041121-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL041121-09A.1-01D	DNA	EFO	SRS2629708	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL041121-09A.1-01D SJMPAL041121_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL041121_D2	SRX3325246	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL041121-09A.1-01D SJMPAL041121_D2 run	sequencing assay	EFO	202	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL041121_D2.bam	SRR6216611	@dbgap@:reads/SRP011999/SRS2629708/SRX3325246/SRR6216611/SRR6216611.sra	2	GRCh37
TARGET-15-SJMPAL041121	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL041121-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL041121-09A.2-01D	DNA	EFO	SRS2629709	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL041121-09A.2-01D SJMPAL041121_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL041121_D3	SRX3325247	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL041121-09A.2-01D SJMPAL041121_D3 run	sequencing assay	EFO	189	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL041121_D3.bam	SRR6216612	@dbgap@:reads/SRP011999/SRS2629709/SRX3325247/SRR6216612/SRR6216612.sra	2	GRCh37
TARGET-15-SJMPAL041122	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL041122-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL041122-09A.1-01D	DNA	EFO	SRS2629710	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL041122-09A.1-01D SJMPAL041122_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL041122_D2	SRX3325248	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL041122-09A.1-01D SJMPAL041122_D2 run	sequencing assay	EFO	193	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL041122_D2.bam	SRR6216613	@dbgap@:reads/SRP011999/SRS2629710/SRX3325248/SRR6216613/SRR6216613.sra	2	GRCh37
TARGET-15-SJMPAL041122	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL041122-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL041122-09A.2-01D	DNA	EFO	SRS2629711	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL041122-09A.2-01D SJMPAL041122_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL041122_D3	SRX3325249	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL041122-09A.2-01D SJMPAL041122_D3 run	sequencing assay	EFO	196	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL041122_D3.bam	SRR6216614	@dbgap@:reads/SRP011999/SRS2629711/SRX3325249/SRR6216614/SRR6216614.sra	2	GRCh37
TARGET-15-SJMPAL041122	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL041122-09A.3	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL041122-09A.3-01D	DNA	EFO	SRS2629712	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL041122-09A.3-01D SJMPAL041122_D4 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL041122_D4	SRX3325250	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL041122-09A.3-01D SJMPAL041122_D4 run	sequencing assay	EFO	196	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL041122_D4.bam	SRR6216615	@dbgap@:reads/SRP011999/SRS2629712/SRX3325250/SRR6216615/SRR6216615.sra	2	GRCh37
TARGET-15-SJMPAL041122	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL041122-14A.1	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL041122-14A.1-01D	DNA	EFO	SRS2629713	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL041122-14A.1-01D SJMPAL041122_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL041122_G1	SRX3325251	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL041122-14A.1-01D SJMPAL041122_G1 run	sequencing assay	EFO	196	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL041122_G1.bam	SRR6216616	@dbgap@:reads/SRP011999/SRS2629713/SRX3325251/SRR6216616/SRR6216616.sra	2	GRCh37
TARGET-15-SJMPAL042787	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL042787-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042787-09A.1-01D	DNA	EFO	SRS2629714	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042787-09A.1-01D SJMPAL042787_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042787_D2	SRX3325252	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042787-09A.1-01D SJMPAL042787_D2 run	sequencing assay	EFO	191	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042787_D2.bam	SRR6216617	@dbgap@:reads/SRP011999/SRS2629714/SRX3325252/SRR6216617/SRR6216617.sra	2	GRCh37
TARGET-15-SJMPAL042787	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL042787-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042787-09A.2-01D	DNA	EFO	SRS2629715	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042787-09A.2-01D SJMPAL042787_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042787_D3	SRX3325253	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042787-09A.2-01D SJMPAL042787_D3 run	sequencing assay	EFO	196	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042787_D3.bam	SRR6216618	@dbgap@:reads/SRP011999/SRS2629715/SRX3325253/SRR6216618/SRR6216618.sra	2	GRCh37
TARGET-15-SJMPAL042787	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL042787-14A.1	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042787-14A.1-01D	DNA	EFO	SRS1761115	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042787-14A.1-01D SJMPAL042787_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042787_G1	SRX3325254	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042787-14A.1-01D SJMPAL042787_G1 run	sequencing assay	EFO	190	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042787_G1.bam	SRR6216619	@dbgap@:reads/SRP011999/SRS1761115/SRX3325254/SRR6216619/SRR6216619.sra	2	GRCh37
TARGET-15-SJMPAL042788	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL042788-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042788-09A.1-01D	DNA	EFO	SRS2629716	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042788-09A.1-01D SJMPAL042788_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042788_D2	SRX3325255	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042788-09A.1-01D SJMPAL042788_D2 run	sequencing assay	EFO	197	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042788_D2.bam	SRR6216620	@dbgap@:reads/SRP011999/SRS2629716/SRX3325255/SRR6216620/SRR6216620.sra	2	GRCh37
TARGET-15-SJMPAL042789	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL042789-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042789-09A.1-01D	DNA	EFO	SRS2629719	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042789-09A.1-01D SJMPAL042789_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042789_D2	SRX3325256	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042789-09A.1-01D SJMPAL042789_D2 run	sequencing assay	EFO	194	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042789_D2.bam	SRR6216621	@dbgap@:reads/SRP011999/SRS2629719/SRX3325256/SRR6216621/SRR6216621.sra	2	GRCh37
TARGET-15-SJMPAL042789	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL042789-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042789-09A.2-01D	DNA	EFO	SRS2629718	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042789-09A.2-01D SJMPAL042789_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042789_D3	SRX3325257	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042789-09A.2-01D SJMPAL042789_D3 run	sequencing assay	EFO	185	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042789_D3.bam	SRR6216622	@dbgap@:reads/SRP011999/SRS2629718/SRX3325257/SRR6216622/SRR6216622.sra	2	GRCh37
TARGET-15-SJMPAL042789	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL042789-09A.3	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042789-09A.3-01D	DNA	EFO	SRS2629720	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042789-09A.3-01D SJMPAL042789_D4 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042789_D4	SRX3325258	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042789-09A.3-01D SJMPAL042789_D4 run	sequencing assay	EFO	201	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042789_D4.bam	SRR6216623	@dbgap@:reads/SRP011999/SRS2629720/SRX3325258/SRR6216623/SRR6216623.sra	2	GRCh37
TARGET-15-SJMPAL042789	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL042789-14A	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042789-14A-01D	DNA	EFO	SRS2629721	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042789-14A-01D SJMPAL042789_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042789_G1	SRX3325259	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042789-14A-01D SJMPAL042789_G1 run	sequencing assay	EFO	185	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042789_G1.bam	SRR6216624	@dbgap@:reads/SRP011999/SRS2629721/SRX3325259/SRR6216624/SRR6216624.sra	2	GRCh37
TARGET-15-SJMPAL042791	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL042791-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042791-09A.1-01D	DNA	EFO	SRS2629722	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042791-09A.1-01D SJMPAL042791_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042791_D2	SRX3325260	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042791-09A.1-01D SJMPAL042791_D2 run	sequencing assay	EFO	193	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042791_D2.bam	SRR6216625	@dbgap@:reads/SRP011999/SRS2629722/SRX3325260/SRR6216625/SRR6216625.sra	2	GRCh37
TARGET-15-SJMPAL042791	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL042791-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042791-09A.2-01D	DNA	EFO	SRS2629723	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042791-09A.2-01D SJMPAL042791_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042791_D3	SRX3325261	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042791-09A.2-01D SJMPAL042791_D3 run	sequencing assay	EFO	190	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042791_D3.bam	SRR6216626	@dbgap@:reads/SRP011999/SRS2629723/SRX3325261/SRR6216626/SRR6216626.sra	2	GRCh37
TARGET-15-SJMPAL042791	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL042791-09A.3	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042791-09A.3-01D	DNA	EFO	SRS2629724	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042791-09A.3-01D SJMPAL042791_D4 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042791_D4	SRX3325262	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042791-09A.3-01D SJMPAL042791_D4 run	sequencing assay	EFO	122	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042791_D4.bam	SRR6216627	@dbgap@:reads/SRP011999/SRS2629724/SRX3325262/SRR6216627/SRR6216627.sra	2	GRCh37
TARGET-15-SJMPAL042792	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL042792-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042792-09A.1-01D	DNA	EFO	SRS2629725	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042792-09A.1-01D SJMPAL042792_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042792_D2	SRX3325263	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042792-09A.1-01D SJMPAL042792_D2 run	sequencing assay	EFO	200	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042792_D2.bam	SRR6216628	@dbgap@:reads/SRP011999/SRS2629725/SRX3325263/SRR6216628/SRR6216628.sra	2	GRCh37
TARGET-15-SJMPAL042792	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL042792-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042792-09A.2-01D	DNA	EFO	SRS2629726	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042792-09A.2-01D SJMPAL042792_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042792_D3	SRX3325264	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042792-09A.2-01D SJMPAL042792_D3 run	sequencing assay	EFO	187	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042792_D3.bam	SRR6216629	@dbgap@:reads/SRP011999/SRS2629726/SRX3325264/SRR6216629/SRR6216629.sra	2	GRCh37
TARGET-15-SJMPAL042792	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL042792-09A.3	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042792-09A.3-01D	DNA	EFO	SRS2629727	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042792-09A.3-01D SJMPAL042792_D4 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042792_D4	SRX3325265	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042792-09A.3-01D SJMPAL042792_D4 run	sequencing assay	EFO	191	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042792_D4.bam	SRR6216630	@dbgap@:reads/SRP011999/SRS2629727/SRX3325265/SRR6216630/SRR6216630.sra	2	GRCh37
TARGET-15-SJMPAL042792	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL042792-14A	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042792-14A-01D	DNA	EFO	SRS2629728	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042792-14A-01D SJMPAL042792_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042792_G1	SRX3325266	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042792-14A-01D SJMPAL042792_G1 run	sequencing assay	EFO	187	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042792_G1.bam	SRR6216631	@dbgap@:reads/SRP011999/SRS2629728/SRX3325266/SRR6216631/SRR6216631.sra	2	GRCh37
TARGET-15-SJMPAL042793	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL042793-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042793-09A.1-01D	DNA	EFO	SRS2629729	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042793-09A.1-01D SJMPAL042793_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042793_D2	SRX3325267	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042793-09A.1-01D SJMPAL042793_D2 run	sequencing assay	EFO	190	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042793_D2.bam	SRR6216632	@dbgap@:reads/SRP011999/SRS2629729/SRX3325267/SRR6216632/SRR6216632.sra	2	GRCh37
TARGET-15-SJMPAL042793	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL042793-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042793-09A.2-01D	DNA	EFO	SRS2629730	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042793-09A.2-01D SJMPAL042793_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042793_D3	SRX3325268	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042793-09A.2-01D SJMPAL042793_D3 run	sequencing assay	EFO	197	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042793_D3.bam	SRR6216633	@dbgap@:reads/SRP011999/SRS2629730/SRX3325268/SRR6216633/SRR6216633.sra	2	GRCh37
TARGET-15-SJMPAL042793	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL042793-09A.3	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042793-09A.3-01D	DNA	EFO	SRS2629731	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042793-09A.3-01D SJMPAL042793_D4 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042793_D4	SRX3325269	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042793-09A.3-01D SJMPAL042793_D4 run	sequencing assay	EFO	196	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042793_D4.bam	SRR6216634	@dbgap@:reads/SRP011999/SRS2629731/SRX3325269/SRR6216634/SRR6216634.sra	2	GRCh37
TARGET-15-SJMPAL042794	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL042794-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042794-09A.1-01D	DNA	EFO	SRS2629732	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042794-09A.1-01D SJMPAL042794_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042794_D2	SRX3325270	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042794-09A.1-01D SJMPAL042794_D2 run	sequencing assay	EFO	200	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042794_D2.bam	SRR6216635	@dbgap@:reads/SRP011999/SRS2629732/SRX3325270/SRR6216635/SRR6216635.sra	2	GRCh37
TARGET-15-SJMPAL042794	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL042794-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042794-09A.2-01D	DNA	EFO	SRS2629733	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042794-09A.2-01D SJMPAL042794_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042794_D3	SRX3325271	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042794-09A.2-01D SJMPAL042794_D3 run	sequencing assay	EFO	195	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042794_D3.bam	SRR6216636	@dbgap@:reads/SRP011999/SRS2629733/SRX3325271/SRR6216636/SRR6216636.sra	2	GRCh37
TARGET-15-SJMPAL042794	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL042794-09A.3	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042794-09A.3-01D	DNA	EFO	SRS2629734	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042794-09A.3-01D SJMPAL042794_D4 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042794_D4	SRX3325272	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042794-09A.3-01D SJMPAL042794_D4 run	sequencing assay	EFO	201	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042794_D4.bam	SRR6216637	@dbgap@:reads/SRP011999/SRS2629734/SRX3325272/SRR6216637/SRR6216637.sra	2	GRCh37
TARGET-15-SJMPAL042794	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL042794-14A.1	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042794-14A.1-01D	DNA	EFO	SRS1761103	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042794-14A.1-01D SJMPAL042794_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042794_G1	SRX3325273	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042794-14A.1-01D SJMPAL042794_G1 run	sequencing assay	EFO	201	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042794_G1.bam	SRR6216638	@dbgap@:reads/SRP011999/SRS1761103/SRX3325273/SRR6216638/SRR6216638.sra	2	GRCh37
TARGET-15-SJMPAL042795	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL042795-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042795-09A.1-01D	DNA	EFO	SRS2629736	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042795-09A.1-01D SJMPAL042795_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042795_D2	SRX3325275	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042795-09A.1-01D SJMPAL042795_D2 run	sequencing assay	EFO	202	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042795_D2.bam	SRR6216640	@dbgap@:reads/SRP011999/SRS2629736/SRX3325275/SRR6216640/SRR6216640.sra	2	GRCh37
TARGET-15-SJMPAL042795	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL042795-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042795-09A.2-01D	DNA	EFO	SRS2629737	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042795-09A.2-01D SJMPAL042795_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042795_D3	SRX3325276	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042795-09A.2-01D SJMPAL042795_D3 run	sequencing assay	EFO	192	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042795_D3.bam	SRR6216641	@dbgap@:reads/SRP011999/SRS2629737/SRX3325276/SRR6216641/SRR6216641.sra	2	GRCh37
TARGET-15-SJMPAL042795	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL042795-09A.3	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042795-09A.3-01D	DNA	EFO	SRS2629739	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042795-09A.3-01D SJMPAL042795_D4 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042795_D4	SRX3325277	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042795-09A.3-01D SJMPAL042795_D4 run	sequencing assay	EFO	198	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042795_D4.bam	SRR6216642	@dbgap@:reads/SRP011999/SRS2629739/SRX3325277/SRR6216642/SRR6216642.sra	2	GRCh37
TARGET-15-SJMPAL042795	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL042795-14A	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042795-14A-01D	DNA	EFO	SRS2862781	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042795-14A-01D SJMPAL042795_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042795_G1	SRX3325274	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042795-14A-01D SJMPAL042795_G1 run	sequencing assay	EFO	181	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042795_G1.bam	SRR6216639	@dbgap@:reads/SRP011999/SRS2862781/SRX3325274/SRR6216639/SRR6216639.sra	2	GRCh37
TARGET-15-SJMPAL042796	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL042796-09A	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042796-09A-01D	DNA	EFO	SRS2495593	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042796-09A-01D SJMPAL042796_D1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042796_D1	SRX3325278	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042796-09A-01D SJMPAL042796_D1 run	sequencing assay	EFO	191	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042796_D1.bam	SRR6216643	@dbgap@:reads/SRP011999/SRS2495593/SRX3325278/SRR6216643/SRR6216643.sra	2	GRCh37
TARGET-15-SJMPAL042797	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL042797-09A	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042797-09A-01D	DNA	EFO	SRS2495594	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042797-09A-01D SJMPAL042797_D1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042797_D1	SRX3325279	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042797-09A-01D SJMPAL042797_D1 run	sequencing assay	EFO	187	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042797_D1.bam	SRR6216644	@dbgap@:reads/SRP011999/SRS2495594/SRX3325279/SRR6216644/SRR6216644.sra	2	GRCh37
TARGET-15-SJMPAL042798	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL042798-09A	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042798-09A-01D	DNA	EFO	SRS2495596	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042798-09A-01D SJMPAL042798_D1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042798_D1	SRX3325280	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042798-09A-01D SJMPAL042798_D1 run	sequencing assay	EFO	187	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042798_D1.bam	SRR6216645	@dbgap@:reads/SRP011999/SRS2495596/SRX3325280/SRR6216645/SRR6216645.sra	2	GRCh37
TARGET-15-SJMPAL042799	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL042799-09A	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042799-09A-01D	DNA	EFO	SRS2495595	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042799-09A-01D SJMPAL042799_D1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042799_D1	SRX3325281	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042799-09A-01D SJMPAL042799_D1 run	sequencing assay	EFO	170	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042799_D1.bam	SRR6216646	@dbgap@:reads/SRP011999/SRS2495595/SRX3325281/SRR6216646/SRR6216646.sra	2	GRCh37
TARGET-15-SJMPAL042800	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL042800-09A	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042800-09A-01D	DNA	EFO	SRS2629740	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042800-09A-01D SJMPAL042800_D1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042800_D1	SRX3325282	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042800-09A-01D SJMPAL042800_D1 run	sequencing assay	EFO	188	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042800_D1.bam	SRR6216647	@dbgap@:reads/SRP011999/SRS2629740/SRX3325282/SRR6216647/SRR6216647.sra	2	GRCh37
TARGET-15-SJMPAL042801	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL042801-09A	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042801-09A-01D	DNA	EFO	SRS2495597	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042801-09A-01D SJMPAL042801_D1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042801_D1	SRX3325283	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042801-09A-01D SJMPAL042801_D1 run	sequencing assay	EFO	186	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042801_D1.bam	SRR6216648	@dbgap@:reads/SRP011999/SRS2495597/SRX3325283/SRR6216648/SRR6216648.sra	2	GRCh37
TARGET-15-SJMPAL042941	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL042941-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042941-09A.1-01D	DNA	EFO	SRS2629741	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042941-09A.1-01D SJMPAL042941_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042941_D2	SRX3325284	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042941-09A.1-01D SJMPAL042941_D2 run	sequencing assay	EFO	194	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042941_D2.bam	SRR6216649	@dbgap@:reads/SRP011999/SRS2629741/SRX3325284/SRR6216649/SRR6216649.sra	2	GRCh37
TARGET-15-SJMPAL042941	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL042941-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042941-09A.2-01D	DNA	EFO	SRS2629742	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042941-09A.2-01D SJMPAL042941_D4 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042941_D4	SRX3325285	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042941-09A.2-01D SJMPAL042941_D4 run	sequencing assay	EFO	200	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042941_D4.bam	SRR6216650	@dbgap@:reads/SRP011999/SRS2629742/SRX3325285/SRR6216650/SRR6216650.sra	2	GRCh37
TARGET-15-SJMPAL042941	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL042941-14A	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042941-14A-01D	DNA	EFO	SRS1761146	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042941-14A-01D SJMPAL042941_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042941_G1	SRX3325286	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042941-14A-01D SJMPAL042941_G1 run	sequencing assay	EFO	191	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042941_G1.bam	SRR6216651	@dbgap@:reads/SRP011999/SRS1761146/SRX3325286/SRR6216651/SRR6216651.sra	2	GRCh37
TARGET-15-SJMPAL042942	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL042942-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042942-09A.1-01D	DNA	EFO	SRS2629743	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042942-09A.1-01D SJMPAL042942_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042942_D2	SRX3325287	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042942-09A.1-01D SJMPAL042942_D2 run	sequencing assay	EFO	192	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042942_D2.bam	SRR6216652	@dbgap@:reads/SRP011999/SRS2629743/SRX3325287/SRR6216652/SRR6216652.sra	2	GRCh37
TARGET-15-SJMPAL042942	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL042942-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042942-09A.2-01D	DNA	EFO	SRS2629746	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042942-09A.2-01D SJMPAL042942_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042942_D3	SRX3325288	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042942-09A.2-01D SJMPAL042942_D3 run	sequencing assay	EFO	202	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042942_D3.bam	SRR6216653	@dbgap@:reads/SRP011999/SRS2629746/SRX3325288/SRR6216653/SRR6216653.sra	2	GRCh37
TARGET-15-SJMPAL042942	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL042942-09A.3	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042942-09A.3-01D	DNA	EFO	SRS2629745	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042942-09A.3-01D SJMPAL042942_D4 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042942_D4	SRX3325289	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042942-09A.3-01D SJMPAL042942_D4 run	sequencing assay	EFO	193	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042942_D4.bam	SRR6216654	@dbgap@:reads/SRP011999/SRS2629745/SRX3325289/SRR6216654/SRR6216654.sra	2	GRCh37
TARGET-15-SJMPAL042942	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL042942-09A.4	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042942-09A.4-01D	DNA	EFO	SRS2629747	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042942-09A.4-01D SJMPAL042942_D5 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042942_D5	SRX3325290	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042942-09A.4-01D SJMPAL042942_D5 run	sequencing assay	EFO	196	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042942_D5.bam	SRR6216655	@dbgap@:reads/SRP011999/SRS2629747/SRX3325290/SRR6216655/SRR6216655.sra	2	GRCh37
TARGET-15-SJMPAL042943	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL042943-09A	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042943-09A-01D	DNA	EFO	SRS2629748	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042943-09A-01D SJMPAL042943_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042943_D2	SRX3325291	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042943-09A-01D SJMPAL042943_D2 run	sequencing assay	EFO	201	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042943_D2.bam	SRR6216656	@dbgap@:reads/SRP011999/SRS2629748/SRX3325291/SRR6216656/SRR6216656.sra	2	GRCh37
TARGET-15-SJMPAL042943	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL042943-14A.1	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL042943-14A.1-01D	DNA	EFO	SRS2629749	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL042943-14A.1-01D SJMPAL042943_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL042943_G1	SRX3325292	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL042943-14A.1-01D SJMPAL042943_G1 run	sequencing assay	EFO	197	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL042943_G1.bam	SRR6216657	@dbgap@:reads/SRP011999/SRS2629749/SRX3325292/SRR6216657/SRR6216657.sra	2	GRCh37
TARGET-15-SJMPAL043508	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Recurrent Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL043508-04A	organism part	EFO	Bone Marrow	NCIt	"Recurrent Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL043508-04A-01D	DNA	EFO	SRS2629750	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL043508-04A-01D SJMPAL043508_R1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL043508_R1	SRX3325293	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL043508-04A-01D SJMPAL043508_R1 run	sequencing assay	EFO	187	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL043508_R1.bam	SRR6216658	@dbgap@:reads/SRP011999/SRS2629750/SRX3325293/SRR6216658/SRR6216658.sra	2	GRCh37
TARGET-15-SJMPAL043508	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Recurrent Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL043508-04B	organism part	EFO	Bone Marrow	NCIt	"Recurrent Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL043508-04B-01D	DNA	EFO	SRS2629751	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL043508-04B-01D SJMPAL043508_R2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL043508_R2	SRX3325294	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL043508-04B-01D SJMPAL043508_R2 run	sequencing assay	EFO	180	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL043508_R2.bam	SRR6216659	@dbgap@:reads/SRP011999/SRS2629751/SRX3325294/SRR6216659/SRR6216659.sra	2	GRCh37
TARGET-15-SJMPAL043509	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Recurrent Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL043509-04A	organism part	EFO	Bone Marrow	NCIt	"Recurrent Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL043509-04A-01D	DNA	EFO	SRS2495599	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL043509-04A-01D SJMPAL043509_D1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL043509_D1	SRX3325295	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL043509-04A-01D SJMPAL043509_D1 run	sequencing assay	EFO	185	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL043509_D1.bam	SRR6216660	@dbgap@:reads/SRP011999/SRS2495599/SRX3325295/SRR6216660/SRR6216660.sra	2	GRCh37
TARGET-15-SJMPAL043510	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL043510-09A	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL043510-09A-01D	DNA	EFO	SRS2495601	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL043510-09A-01D SJMPAL043510_D1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL043510_D1	SRX3325296	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL043510-09A-01D SJMPAL043510_D1 run	sequencing assay	EFO	186	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL043510_D1.bam	SRR6216661	@dbgap@:reads/SRP011999/SRS2495601/SRX3325296/SRR6216661/SRR6216661.sra	2	GRCh37
TARGET-15-SJMPAL043512	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL043512-09A	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL043512-09A-01D	DNA	EFO	SRS2629752	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL043512-09A-01D SJMPAL043512_D1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL043512_D1	SRX3325297	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL043512-09A-01D SJMPAL043512_D1 run	sequencing assay	EFO	144	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL043512_D1.bam	SRR6216662	@dbgap@:reads/SRP011999/SRS2629752/SRX3325297/SRR6216662/SRR6216662.sra	2	GRCh37
TARGET-15-SJMPAL043512	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL043512-15A	organism part	EFO	Bone Marrow	NCIt	"Fibroblasts from Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL043512-15A-01D	DNA	EFO	SRS2629753	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL043512-15A-01D SJMPAL043512_G2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL043512_G2	SRX3325298	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL043512-15A-01D SJMPAL043512_G2 run	sequencing assay	EFO	186	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL043512_G2.bam	SRR6216663	@dbgap@:reads/SRP011999/SRS2629753/SRX3325298/SRR6216663/SRR6216663.sra	2	GRCh37
TARGET-15-SJMPAL043514	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL043514-09A	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL043514-09A-01D	DNA	EFO	SRS2495603	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL043514-09A-01D SJMPAL043514_D1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL043514_D1	SRX3325299	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL043514-09A-01D SJMPAL043514_D1 run	sequencing assay	EFO	187	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL043514_D1.bam	SRR6216664	@dbgap@:reads/SRP011999/SRS2495603/SRX3325299/SRR6216664/SRR6216664.sra	2	GRCh37
TARGET-15-SJMPAL043514	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL043514-15A	organism part	EFO	Bone Marrow	NCIt	"Fibroblasts from Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL043514-15A-01D	DNA	EFO	SRS2629754	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL043514-15A-01D SJMPAL043514_G2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL043514_G2	SRX3325300	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL043514-15A-01D SJMPAL043514_G2 run	sequencing assay	EFO	192	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL043514_G2.bam	SRR6216665	@dbgap@:reads/SRP011999/SRS2629754/SRX3325300/SRR6216665/SRR6216665.sra	2	GRCh37
TARGET-15-SJMPAL043773	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Recurrent Childhood Mixed Phenotype Acute Leukemia	NCIt	Discovery	TARGET-15-SJMPAL043773-40A	organism part	EFO	Peripheral Blood	NCIt	"Recurrent Blood Derived Cancer - Peripheral Blood"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL043773-40A-01D	DNA	EFO	SRS2495602	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL043773-40A-01D SJMPAL043773_R1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL043773_R1	SRX3325324	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL043773-40A-01D SJMPAL043773_R1 run	sequencing assay	EFO	174	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL043773_R1.bam	SRR6216689	@dbgap@:reads/SRP011999/SRS2495602/SRX3325324/SRR6216689/SRR6216689.sra	2	GRCh37
TARGET-15-SJMPAL044945	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL044945-09A	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL044945-09A-01D	DNA	EFO	SRS2629755	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL044945-09A-01D SJMPAL044945_D1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL044945_D1	SRX3325301	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL044945-09A-01D SJMPAL044945_D1 run	sequencing assay	EFO	182	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL044945_D1.bam	SRR6216666	@dbgap@:reads/SRP011999/SRS2629755/SRX3325301/SRR6216666/SRR6216666.sra	2	GRCh37
TARGET-15-SJMPAL044948	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL044948-09A	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL044948-09A-01D	DNA	EFO	SRS2495604	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL044948-09A-01D SJMPAL044948_D1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL044948_D1	SRX3325302	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL044948-09A-01D SJMPAL044948_D1 run	sequencing assay	EFO	187	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL044948_D1.bam	SRR6216667	@dbgap@:reads/SRP011999/SRS2495604/SRX3325302/SRR6216667/SRR6216667.sra	2	GRCh37
TARGET-15-SJMPAL044949	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL044949-09A	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL044949-09A-01D	DNA	EFO	SRS2495605	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL044949-09A-01D SJMPAL044949_D1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL044949_D1	SRX3325303	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL044949-09A-01D SJMPAL044949_D1 run	sequencing assay	EFO	188	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL044949_D1.bam	SRR6216668	@dbgap@:reads/SRP011999/SRS2495605/SRX3325303/SRR6216668/SRR6216668.sra	2	GRCh37
TARGET-15-SJMPAL044950	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL044950-09A	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL044950-09A-01D	DNA	EFO	SRS2495606	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL044950-09A-01D SJMPAL044950_D1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL044950_D1	SRX3325304	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL044950-09A-01D SJMPAL044950_D1 run	sequencing assay	EFO	191	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL044950_D1.bam	SRR6216669	@dbgap@:reads/SRP011999/SRS2495606/SRX3325304/SRR6216669/SRR6216669.sra	2	GRCh37
TARGET-15-SJMPAL044950	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL044950-14A.1	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL044950-14A.1-01D	DNA	EFO	SRS2629756	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL044950-14A.1-01D SJMPAL044950_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL044950_G1	SRX3325305	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL044950-14A.1-01D SJMPAL044950_G1 run	sequencing assay	EFO	176	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL044950_G1.bam	SRR6216670	@dbgap@:reads/SRP011999/SRS2629756/SRX3325305/SRR6216670/SRR6216670.sra	2	GRCh37
TARGET-15-SJMPAL044956	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL044956-09A	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL044956-09A-01D	DNA	EFO	SRS2629757	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL044956-09A-01D SJMPAL044956_D1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL044956_D1	SRX3325306	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL044956-09A-01D SJMPAL044956_D1 run	sequencing assay	EFO	182	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL044956_D1.bam	SRR6216671	@dbgap@:reads/SRP011999/SRS2629757/SRX3325306/SRR6216671/SRR6216671.sra	2	GRCh37
TARGET-15-SJMPAL044956	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL044956-14A	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL044956-14A-01D	DNA	EFO	SRS2629758	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL044956-14A-01D SJMPAL044956_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL044956_G1	SRX3325307	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL044956-14A-01D SJMPAL044956_G1 run	sequencing assay	EFO	181	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL044956_G1.bam	SRR6216672	@dbgap@:reads/SRP011999/SRS2629758/SRX3325307/SRR6216672/SRR6216672.sra	2	GRCh37
TARGET-15-SJMPAL044957	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL044957-09A	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL044957-09A-01D	DNA	EFO	SRS2629759	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL044957-09A-01D SJMPAL044957_D1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL044957_D1	SRX3325308	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL044957-09A-01D SJMPAL044957_D1 run	sequencing assay	EFO	184	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL044957_D1.bam	SRR6216673	@dbgap@:reads/SRP011999/SRS2629759/SRX3325308/SRR6216673/SRR6216673.sra	2	GRCh37
TARGET-15-SJMPAL044957	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL044957-15A	organism part	EFO	Bone Marrow	NCIt	"Fibroblasts from Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL044957-15A-01D	DNA	EFO	SRS2629761	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL044957-15A-01D SJMPAL044957_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL044957_G1	SRX3325309	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL044957-15A-01D SJMPAL044957_G1 run	sequencing assay	EFO	188	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL044957_G1.bam	SRR6216674	@dbgap@:reads/SRP011999/SRS2629761/SRX3325309/SRR6216674/SRR6216674.sra	2	GRCh37
TARGET-15-SJMPAL046466	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL046466-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL046466-09A.1-01D	DNA	EFO	SRS2495608	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL046466-09A.1-01D SJMPAL046466_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL046466_D2	SRX3325310	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL046466-09A.1-01D SJMPAL046466_D2 run	sequencing assay	EFO	192	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL046466_D2.bam	SRR6216675	@dbgap@:reads/SRP011999/SRS2495608/SRX3325310/SRR6216675/SRR6216675.sra	2	GRCh37
TARGET-15-SJMPAL046466	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL046466-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL046466-09A.2-01D	DNA	EFO	SRS2629798	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL046466-09A.2-01D SJMPAL046466_D4 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL046466_D4	SRX3325311	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL046466-09A.2-01D SJMPAL046466_D4 run	sequencing assay	EFO	192	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL046466_D4.bam	SRR6216676	@dbgap@:reads/SRP011999/SRS2629798/SRX3325311/SRR6216676/SRR6216676.sra	2	GRCh37
TARGET-15-SJMPAL046466	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL046466-14A.1	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL046466-14A.1-01D	DNA	EFO	SRS2629760	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL046466-14A.1-01D SJMPAL046466_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL046466_G1	SRX3325312	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL046466-14A.1-01D SJMPAL046466_G1 run	sequencing assay	EFO	202	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL046466_G1.bam	SRR6216677	@dbgap@:reads/SRP011999/SRS2629760/SRX3325312/SRR6216677/SRR6216677.sra	2	GRCh37
TARGET-15-SJMPAL046468	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL046468-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL046468-09A.1-01D	DNA	EFO	SRS2495610	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL046468-09A.1-01D SJMPAL046468_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL046468_D2	SRX3325313	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL046468-09A.1-01D SJMPAL046468_D2 run	sequencing assay	EFO	192	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL046468_D2.bam	SRR6216678	@dbgap@:reads/SRP011999/SRS2495610/SRX3325313/SRR6216678/SRR6216678.sra	2	GRCh37
TARGET-15-SJMPAL046468	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL046468-14A.1	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL046468-14A.1-01D	DNA	EFO	SRS2629763	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL046468-14A.1-01D SJMPAL046468_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL046468_G1	SRX3325314	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL046468-14A.1-01D SJMPAL046468_G1 run	sequencing assay	EFO	191	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL046468_G1.bam	SRR6216679	@dbgap@:reads/SRP011999/SRS2629763/SRX3325314/SRR6216679/SRR6216679.sra	2	GRCh37
TARGET-15-SJMPAL046469	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL046469-09A	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL046469-09A-01D	DNA	EFO	SRS2495611	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL046469-09A-01D SJMPAL046469_D1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL046469_D1	SRX3325315	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL046469-09A-01D SJMPAL046469_D1 run	sequencing assay	EFO	169	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL046469_D1.bam	SRR6216680	@dbgap@:reads/SRP011999/SRS2495611/SRX3325315/SRR6216680/SRR6216680.sra	2	GRCh37
TARGET-15-SJMPAL046469	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL046469-14A	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL046469-14A-01D	DNA	EFO	SRS2629764	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL046469-14A-01D SJMPAL046469_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL046469_G1	SRX3325316	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL046469-14A-01D SJMPAL046469_G1 run	sequencing assay	EFO	184	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL046469_G1.bam	SRR6216681	@dbgap@:reads/SRP011999/SRS2629764/SRX3325316/SRR6216681/SRR6216681.sra	2	GRCh37
TARGET-15-SJMPAL046470	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL046470-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL046470-09A.1-01D	DNA	EFO	SRS2495612	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL046470-09A.1-01D SJMPAL046470_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL046470_D2	SRX3325317	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL046470-09A.1-01D SJMPAL046470_D2 run	sequencing assay	EFO	187	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL046470_D2.bam	SRR6216682	@dbgap@:reads/SRP011999/SRS2495612/SRX3325317/SRR6216682/SRR6216682.sra	2	GRCh37
TARGET-15-SJMPAL046470	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL046470-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL046470-09A.2-01D	DNA	EFO	SRS2629762	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL046470-09A.2-01D SJMPAL046470_D3 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL046470_D3	SRX3325318	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL046470-09A.2-01D SJMPAL046470_D3 run	sequencing assay	EFO	191	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL046470_D3.bam	SRR6216683	@dbgap@:reads/SRP011999/SRS2629762/SRX3325318/SRR6216683/SRR6216683.sra	2	GRCh37
TARGET-15-SJMPAL046470	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	female	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL046470-15A	organism part	EFO	Bone Marrow	NCIt	"Fibroblasts from Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL046470-15A-01D	DNA	EFO	SRS2629766	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL046470-15A-01D SJMPAL046470_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL046470_G1	SRX3325319	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL046470-15A-01D SJMPAL046470_G1 run	sequencing assay	EFO	166	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL046470_G1.bam	SRR6216684	@dbgap@:reads/SRP011999/SRS2629766/SRX3325319/SRR6216684/SRR6216684.sra	2	GRCh37
TARGET-15-SJMPAL046471	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL046471-09A.1	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL046471-09A.1-01D	DNA	EFO	SRS2495613	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL046471-09A.1-01D SJMPAL046471_D2 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL046471_D2	SRX3325320	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL046471-09A.1-01D SJMPAL046471_D2 run	sequencing assay	EFO	197	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL046471_D2.bam	SRR6216685	@dbgap@:reads/SRP011999/SRS2495613/SRX3325320/SRR6216685/SRR6216685.sra	2	GRCh37
TARGET-15-SJMPAL046471	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL046471-09A.2	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL046471-09A.2-01D	DNA	EFO	SRS2629767	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL046471-09A.2-01D SJMPAL046471_D4 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL046471_D4	SRX3325321	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL046471-09A.2-01D SJMPAL046471_D4 run	sequencing assay	EFO	199	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL046471_D4.bam	SRR6216686	@dbgap@:reads/SRP011999/SRS2629767/SRX3325321/SRR6216686/SRR6216686.sra	2	GRCh37
TARGET-15-SJMPAL046471	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL046471-14A.1	organism part	EFO	Bone Marrow	NCIt	"Bone Marrow Normal"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL046471-14A.1-01D	DNA	EFO	SRS2629765	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL046471-14A.1-01D SJMPAL046471_G1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL046471_G1	SRX3325322	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL046471-14A.1-01D SJMPAL046471_G1 run	sequencing assay	EFO	192	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL046471_G1.bam	SRR6216687	@dbgap@:reads/SRP011999/SRS2629765/SRX3325322/SRR6216687/SRR6216687.sra	2	GRCh37
TARGET-15-SJMPAL046472	Children's Oncology Group	whole organism	EFO	Homo sapiens	NCBITaxon	male	NCIt	Childhood Mixed Phenotype Acute Leukemia	NCIt		TARGET-15-SJMPAL046472-09A	organism part	EFO	Bone Marrow	NCIt	"Primary Blood Derived Cancer - Bone Marrow"	stjude.org:Protocol:DNA-Extraction-Qiagen-QIAamp:01	St. Jude Children's Research Hospital	TARGET-15-SJMPAL046472-09A-01D	DNA	EFO	SRS2495614	stjude.org:Protocol:WXS-LibraryPrep-Illumina:01	stjude.org:Protocol:WXS-ExomeCapture-Illumina:01	STJUDE	TARGET-15-SJMPAL046472-09A-01D SJMPAL046472_D1 library	PAIRED	GENOMIC	WXS	RANDOM	SJMPAL046472_D1	SRX3325323	""Target capture utilized Illumina Nextera rapid capture exome kit and supplied hybridization and associated reagents. Library quality control was performed using a Victor fluorescence plate reader with Quant-it dsDNA reagents for pre-pool quantitation, and Agilent Bio-analyzer 2200 for final library quantitation. Paired-end sequencing was performed using Illumina HiSeq 2500 with read length 100 bp.""	stjude.org:Protocol:WXS-Sequence-Illumina-HiSeq2500:01	StJude	TARGET-15-SJMPAL046472-09A-01D SJMPAL046472_D1 run	sequencing assay	EFO	183	stjude.org:Protocol:WXS-BaseCall-Illumina:01	stjude.org:Protocol:WXS-ReadAlign:01	SJMPAL046472_D1.bam	SRR6216688	@dbgap@:reads/SRP011999/SRS2495614/SRX3325323/SRR6216688/SRR6216688.sra	2	GRCh37
